| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX36 ATP6V1B2 ABCA1 SETX MYO9B BLM KIF3B ACSBG1 ACSF3 DDX41 HSPA4 HSPA9 DYNC1H1 ANXA1 DDX60 RFC4 DHX30 DNAH1 ATP2A1 ATP2A2 ATP2A3 ATP2B2 | 1.61e-07 | 614 | 195 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 2.76e-06 | 11 | 195 | 4 | GO:0005388 | |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 3.64e-06 | 4 | 195 | 3 | GO:0030899 | |
| GeneOntologyMolecularFunction | small GTPase binding | KNTC1 ABCA1 MYO9B RGPD1 NCF2 KIF3B MFN2 RABGGTB DOCK1 RGPD8 ARHGDIB PRKCH RAB11FIP4 | 1.72e-05 | 321 | 195 | 13 | GO:0031267 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DHX36 ABCA1 MYO9B BLM KIF3B DDX41 HSPA9 DYNC1H1 DDX60 RFC4 DHX30 ATP2A1 ATP2A2 ATP2A3 ATP2B2 | 3.02e-05 | 441 | 195 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | DNA helicase activity | 3.13e-05 | 62 | 195 | 6 | GO:0003678 | |
| GeneOntologyMolecularFunction | GTPase binding | KNTC1 ABCA1 MYO9B RGPD1 NCF2 KIF3B MFN2 RABGGTB DOCK1 RGPD8 ARHGDIB PRKCH RAB11FIP4 | 5.65e-05 | 360 | 195 | 13 | GO:0051020 |
| GeneOntologyMolecularFunction | structural constituent of muscle | 6.01e-05 | 43 | 195 | 5 | GO:0008307 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DHX36 ABCA1 MYO9B TUFM BLM KIF3B MFN2 DDX41 HSPA9 DYNC1H1 ADSS1 RAB31 DDX60 RFC4 DHX30 ARHGDIB ATP2A1 ATP2A2 ATP2A3 ATP2B2 | 7.53e-05 | 775 | 195 | 20 | GO:0017111 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.03e-04 | 48 | 195 | 5 | GO:0016620 | |
| GeneOntologyMolecularFunction | helicase activity | 1.65e-04 | 158 | 195 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 2.15e-04 | 56 | 195 | 5 | GO:0016903 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DHX36 ABCA1 MYO9B TUFM BLM KIF3B MFN2 DDX41 HSPA9 DYNC1H1 ADSS1 RAB31 DDX60 RFC4 DHX30 ARHGDIB ATP2A1 ATP2A2 ATP2A3 ATP2B2 | 2.17e-04 | 839 | 195 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DHX36 ABCA1 MYO9B TUFM BLM KIF3B MFN2 DDX41 HSPA9 DYNC1H1 ADSS1 RAB31 DDX60 RFC4 DHX30 ARHGDIB ATP2A1 ATP2A2 ATP2A3 ATP2B2 | 2.21e-04 | 840 | 195 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DHX36 ABCA1 MYO9B TUFM BLM KIF3B MFN2 DDX41 HSPA9 DYNC1H1 ADSS1 RAB31 DDX60 RFC4 DHX30 ARHGDIB ATP2A1 ATP2A2 ATP2A3 ATP2B2 | 2.21e-04 | 840 | 195 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | annealing activity | 3.08e-04 | 14 | 195 | 3 | GO:0140666 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 3.48e-04 | 62 | 195 | 5 | GO:0019829 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 3.83e-04 | 15 | 195 | 3 | GO:0004029 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 4.07e-04 | 36 | 195 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 4.07e-04 | 36 | 195 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.34e-04 | 188 | 195 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor | 5.62e-04 | 4 | 195 | 2 | GO:0016899 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase [NAD(P)+] activity | 5.64e-04 | 17 | 195 | 3 | GO:0004030 | |
| GeneOntologyMolecularFunction | lipase inhibitor activity | 6.72e-04 | 18 | 195 | 3 | GO:0055102 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 7.07e-04 | 109 | 195 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | calcium ion binding | EFCAB5 CLSTN2 SYT1 PCDHGA7 ANXA1 PCDHGA5 FAT3 PCDHA4 PCDHA1 SYT2 SLC8A1 HMCN1 RAB11FIP4 SNCB ATP2A1 ATP2A2 ATP2B2 | 1.12e-03 | 749 | 195 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 1.39e-03 | 6 | 195 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.56e-03 | 127 | 195 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.76e-03 | 130 | 195 | 6 | GO:0005200 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.86e-03 | 178 | 195 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | 3-chloroallyl aldehyde dehydrogenase activity | 1.93e-03 | 7 | 195 | 2 | GO:0004028 | |
| GeneOntologyMolecularFunction | thyroid hormone binding | 1.93e-03 | 7 | 195 | 2 | GO:0070324 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 7.45e-06 | 29 | 197 | 5 | GO:1903779 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | CFH ATP6V1B2 ACAT1 ACLY PFKP NDUFA9 ACSBG1 PKM ACSF3 DLD PYGL ADSS1 MTHFD1 AASS NT5C2 ENO2 ATP2B2 | 1.80e-05 | 540 | 197 | 17 | GO:0019693 |
| GeneOntologyBiologicalProcess | membrane organization | ABCA1 NFASC MFN2 SYT1 PLEC HSPA4 HSPA9 DOCK1 MIA3 SORBS2 RAB31 AKAP5 PACSIN1 ANXA1 ATG2B SYT2 FCHO2 CRKL NUP155 USO1 ADAM2 ATP2A2 MUSK | 2.23e-05 | 914 | 197 | 23 | GO:0061024 |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | CFH ATP6V1B2 ACAT1 ACLY PFKP NDUFA9 ACSBG1 PKM ACSF3 DLD ADSS1 MTHFD1 AASS NT5C2 ENO2 ATP2B2 | 3.50e-05 | 512 | 197 | 16 | GO:0009150 |
| GeneOntologyBiologicalProcess | mononuclear cell migration | 4.00e-05 | 258 | 197 | 11 | GO:0071674 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 4.93e-05 | 100 | 197 | 7 | GO:0061337 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | CFH ATP6V1B2 ACAT1 ACLY PFKP NDUFA9 ACSBG1 PKM ACSF3 DLD ADSS1 MTHFD1 AASS NT5C2 ENO2 ATP2B2 | 5.63e-05 | 533 | 197 | 16 | GO:0009259 |
| GeneOntologyBiologicalProcess | cell junction organization | DHX36 PECAM1 HNRNPM NFASC CLSTN2 ITGAV PLXNB2 CHRNA1 ADD1 FMN1 MFN2 PLEC DOCK1 SORBS2 AKAP5 KALRN NBEA TEK CRKL PRKCH SNCB ATP2B2 MUSK | 5.95e-05 | 974 | 197 | 23 | GO:0034330 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | EPHB4 CFH PECAM1 BBS4 NFASC KLHL41 NEB ITGAV PLXNB2 ADD1 FMN1 PDCL3 PKM MFN2 ADAM17 C5 CDC73 PLEC ALDH1A3 DOCK1 FLT1 MIA3 NAA15 ANXA1 FAT3 TEK MTHFD1 PLEKHO1 ATP2B2 MYBPC3 | 7.55e-05 | 1483 | 197 | 30 | GO:0048646 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PECAM1 CLSTN2 PLXNB2 PCDHGA7 PCDHGA5 FAT3 PCDHA4 PCDHA1 HMCN1 | 8.10e-05 | 187 | 197 | 9 | GO:0007156 |
| GeneOntologyBiologicalProcess | calcium ion transport from cytosol to endoplasmic reticulum | 9.08e-05 | 2 | 197 | 2 | GO:1903515 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid metabolic process | 9.57e-05 | 111 | 197 | 7 | GO:0043648 | |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | CFH ATP6V1B2 ACAT1 ACLY NCF2 PFKP NDUFA9 ACSBG1 PKM ACSF3 DLD ADSS1 MTHFD1 AASS NT5C2 ENO2 ATP2B2 | 9.81e-05 | 619 | 197 | 17 | GO:0006163 |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 9.93e-05 | 150 | 197 | 8 | GO:0050773 | |
| GeneOntologyBiologicalProcess | DNA duplex unwinding | 1.02e-04 | 78 | 197 | 6 | GO:0032508 | |
| GeneOntologyBiologicalProcess | acyl-CoA biosynthetic process | 1.02e-04 | 49 | 197 | 5 | GO:0071616 | |
| GeneOntologyBiologicalProcess | thioester biosynthetic process | 1.02e-04 | 49 | 197 | 5 | GO:0035384 | |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | DHX36 LARP4 PLXNB2 BRWD3 MFN2 SYT1 AKAP5 KALRN ANXA1 SYT2 PLEKHO1 | 1.63e-04 | 302 | 197 | 11 | GO:0022604 |
| GeneOntologyBiologicalProcess | DNA geometric change | 1.75e-04 | 86 | 197 | 6 | GO:0032392 | |
| GeneOntologyBiologicalProcess | actin filament-based process | TPM2 MYO9B PECAM1 BBS4 KLHL41 NEB ADD1 FMN1 PDCL3 SCN7A MFN2 PLEC PACSIN1 ANXA1 APOA1 AKAP9 NUP155 HMCN1 ATP2A1 ATP2A2 MYBPC3 | 1.79e-04 | 912 | 197 | 21 | GO:0030029 |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | CFH ATP6V1B2 ACAT1 ACLY NCF2 PFKP NDUFA9 ACSBG1 PKM ACSF3 DLD ADSS1 MTHFD1 AASS NT5C2 ENO2 ATP2B2 | 1.82e-04 | 652 | 197 | 17 | GO:0072521 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.87e-04 | 87 | 197 | 6 | GO:0086001 | |
| GeneOntologyBiologicalProcess | muscle cell development | KLHL41 NEB MFN2 COL14A1 PLEC SORBS2 SLC8A1 CTCF ATP2A2 MYBPC3 | 2.02e-04 | 259 | 197 | 10 | GO:0055001 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 2.22e-04 | 127 | 197 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | KLHL41 CHRNA1 SCN7A SLC8A1 AKAP9 NUP155 ATP2A1 ATP2A2 MYBPC3 | 2.49e-04 | 217 | 197 | 9 | GO:0006941 |
| GeneOntologyBiologicalProcess | positive regulation of endoplasmic reticulum calcium ion concentration | 2.71e-04 | 3 | 197 | 2 | GO:0032470 | |
| GeneOntologyBiologicalProcess | DNA conformation change | 2.85e-04 | 94 | 197 | 6 | GO:0071103 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate biosynthetic process | 2.91e-04 | 61 | 197 | 5 | GO:0033866 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate biosynthetic process | 2.91e-04 | 61 | 197 | 5 | GO:0034030 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate biosynthetic process | 2.91e-04 | 61 | 197 | 5 | GO:0034033 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | CFH ATP6V1B2 ACAT1 ACLY NCF2 PFKP NDUFA9 ACSBG1 PKM ACSF3 DLD ADSS1 MTHFD1 AASS NT5C2 ENO2 ATP2B2 | 3.18e-04 | 684 | 197 | 17 | GO:0009117 |
| GeneOntologyBiologicalProcess | synaptic vesicle endocytosis | 3.20e-04 | 96 | 197 | 6 | GO:0048488 | |
| GeneOntologyBiologicalProcess | neutrophil homeostasis | 3.35e-04 | 35 | 197 | 4 | GO:0001780 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | CFH ATP6V1B2 ACAT1 ACLY NCF2 PFKP NDUFA9 ACSBG1 PKM ACSF3 DLD ADSS1 MTHFD1 AASS NT5C2 ENO2 ATP2B2 | 3.58e-04 | 691 | 197 | 17 | GO:0006753 |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle acetylcholine-gated channel clustering | 3.59e-04 | 15 | 197 | 3 | GO:1904393 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | ABCA1 MYO9B ITGAV MFN2 KALRN APOA1 TEK DENND3 CRKL ARHGDIB MUSK | 3.75e-04 | 333 | 197 | 11 | GO:0051056 |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | CFH ATP6V1B2 ACAT1 ACLY NCF2 PFKP NDUFA9 CMAS ACSBG1 PKM ACSF3 DLD ADSS1 MTHFD1 AASS NT5C2 ENO2 ATP2B2 | 4.21e-04 | 767 | 197 | 18 | GO:0055086 |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 4.43e-04 | 102 | 197 | 6 | GO:0140238 | |
| GeneOntologyBiologicalProcess | neuromuscular junction development | 4.84e-04 | 68 | 197 | 5 | GO:0007528 | |
| GeneOntologyBiologicalProcess | acetyl-CoA metabolic process | 5.11e-04 | 39 | 197 | 4 | GO:0006084 | |
| GeneOntologyBiologicalProcess | cellular response to high density lipoprotein particle stimulus | 5.38e-04 | 4 | 197 | 2 | GO:0071403 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 6.15e-05 | 9 | 192 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | contractile muscle fiber | TPM2 PECAM1 KLHL41 CMYA5 NEB PLEC SORBS2 SLC8A1 FXR1 ATP2A1 MYBPC3 | 8.06e-05 | 290 | 192 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.19e-04 | 11 | 192 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | myelin sheath | 1.86e-04 | 217 | 192 | 9 | GO:0043209 | |
| GeneOntologyCellularComponent | myofibril | 2.26e-04 | 273 | 192 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | sarcomere | 5.11e-04 | 249 | 192 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | sarcoplasm | 6.51e-04 | 114 | 192 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | ruffle | 6.54e-04 | 206 | 192 | 8 | GO:0001726 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 7.66e-04 | 45 | 192 | 4 | GO:0033017 | |
| Domain | P-type_ATPase_IIA | 1.10e-06 | 3 | 194 | 3 | IPR005782 | |
| Domain | Hydrolase_3 | 2.26e-06 | 10 | 194 | 4 | PF08282 | |
| Domain | TPR_1 | 4.39e-06 | 90 | 194 | 8 | IPR001440 | |
| Domain | TPR_1 | 4.39e-06 | 90 | 194 | 8 | PF00515 | |
| Domain | ATPase_P-typ_TM_dom | 1.86e-05 | 16 | 194 | 4 | IPR023298 | |
| Domain | - | 1.86e-05 | 16 | 194 | 4 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 2.42e-05 | 17 | 194 | 4 | IPR006068 | |
| Domain | Cation_ATPase_C | 2.42e-05 | 17 | 194 | 4 | PF00689 | |
| Domain | Cation_ATPase_N | 3.08e-05 | 18 | 194 | 4 | PF00690 | |
| Domain | Cation_ATPase_N | 3.08e-05 | 18 | 194 | 4 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 3.87e-05 | 19 | 194 | 4 | IPR004014 | |
| Domain | SUI1_euk | 1.07e-04 | 2 | 194 | 2 | IPR005874 | |
| Domain | Synaptotagmin1 | 1.07e-04 | 2 | 194 | 2 | IPR015428 | |
| Domain | Grip | 1.71e-04 | 11 | 194 | 3 | SM00755 | |
| Domain | GRIP | 1.71e-04 | 11 | 194 | 3 | PF01465 | |
| Domain | HAD-like_dom | 1.72e-04 | 79 | 194 | 6 | IPR023214 | |
| Domain | TPR-contain_dom | 1.75e-04 | 150 | 194 | 8 | IPR013026 | |
| Domain | IGc2 | 1.80e-04 | 235 | 194 | 10 | SM00408 | |
| Domain | Ig_sub2 | 1.80e-04 | 235 | 194 | 10 | IPR003598 | |
| Domain | Ran_BP1 | 2.27e-04 | 12 | 194 | 3 | PF00638 | |
| Domain | RANBD1 | 2.27e-04 | 12 | 194 | 3 | PS50196 | |
| Domain | GRIP_dom | 2.27e-04 | 12 | 194 | 3 | IPR000237 | |
| Domain | GRIP | 2.27e-04 | 12 | 194 | 3 | PS50913 | |
| Domain | RanBD | 2.92e-04 | 13 | 194 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 2.92e-04 | 13 | 194 | 3 | IPR000156 | |
| Domain | fn3 | 2.96e-04 | 162 | 194 | 8 | PF00041 | |
| Domain | - | 3.23e-04 | 32 | 194 | 4 | 3.40.1110.10 | |
| Domain | - | 3.23e-04 | 32 | 194 | 4 | 2.70.150.10 | |
| Domain | TPR_REGION | 3.35e-04 | 165 | 194 | 8 | PS50293 | |
| Domain | TPR | 3.35e-04 | 165 | 194 | 8 | PS50005 | |
| Domain | TPR | 4.02e-04 | 129 | 194 | 7 | SM00028 | |
| Domain | ATPase_P-typ_cyto_domN | 4.59e-04 | 35 | 194 | 4 | IPR023299 | |
| Domain | TPR_repeat | 4.84e-04 | 133 | 194 | 7 | IPR019734 | |
| Domain | SH3_domain | 5.03e-04 | 220 | 194 | 9 | IPR001452 | |
| Domain | ATPase_P-typ_P_site | 5.13e-04 | 36 | 194 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 5.13e-04 | 36 | 194 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 5.13e-04 | 36 | 194 | 4 | PS00154 | |
| Domain | Ald_DH_CS_GLU | 5.59e-04 | 16 | 194 | 3 | IPR029510 | |
| Domain | Cadherin_tail | 5.70e-04 | 37 | 194 | 4 | PF15974 | |
| Domain | ATPase_P-typ_transduc_dom_A | 5.70e-04 | 37 | 194 | 4 | IPR008250 | |
| Domain | Cadherin_CBD | 5.70e-04 | 37 | 194 | 4 | IPR031904 | |
| Domain | E1-E2_ATPase | 5.70e-04 | 37 | 194 | 4 | PF00122 | |
| Domain | - | EPHB4 PECAM1 NFASC CMYA5 PLXNB2 COL14A1 FLT1 MXRA5 KALRN TEK TGM1 CD4 HMCN1 TREM1 CNTN3 MUSK MYBPC3 | 5.73e-04 | 663 | 194 | 17 | 2.60.40.10 |
| Domain | - | 6.35e-04 | 4 | 194 | 2 | 3.30.780.10 | |
| Domain | SUI1 | 6.35e-04 | 4 | 194 | 2 | PF01253 | |
| Domain | SUI1 | 6.35e-04 | 4 | 194 | 2 | PS50296 | |
| Domain | Ald_DH_CS_CYS | 6.74e-04 | 17 | 194 | 3 | IPR016160 | |
| Domain | FN3 | 7.16e-04 | 185 | 194 | 8 | SM00060 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 8.03e-04 | 18 | 194 | 3 | PS00070 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 8.03e-04 | 18 | 194 | 3 | PS00687 | |
| Domain | Ig_I-set | 8.52e-04 | 190 | 194 | 8 | IPR013098 | |
| Domain | I-set | 8.52e-04 | 190 | 194 | 8 | PF07679 | |
| Domain | - | 9.46e-04 | 19 | 194 | 3 | 3.40.605.10 | |
| Domain | Aldedh | 9.46e-04 | 19 | 194 | 3 | PF00171 | |
| Domain | Ald_DH_C | 9.46e-04 | 19 | 194 | 3 | IPR016163 | |
| Domain | Ald_DH_N | 9.46e-04 | 19 | 194 | 3 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 9.46e-04 | 19 | 194 | 3 | IPR016161 | |
| Domain | Aldehyde_DH_dom | 9.46e-04 | 19 | 194 | 3 | IPR015590 | |
| Domain | - | 9.46e-04 | 19 | 194 | 3 | 3.40.309.10 | |
| Domain | DEAD/DEAH_box_helicase_dom | 9.74e-04 | 73 | 194 | 5 | IPR011545 | |
| Domain | DEAD | 9.74e-04 | 73 | 194 | 5 | PF00270 | |
| Domain | SUI1 | 1.05e-03 | 5 | 194 | 2 | IPR001950 | |
| Domain | Ig-like_fold | EPHB4 PECAM1 NFASC CMYA5 PLXNB2 COL14A1 FLT1 MXRA5 KALRN TEK TGM1 CD4 HMCN1 TREM1 CNTN3 MUSK MYBPC3 | 1.14e-03 | 706 | 194 | 17 | IPR013783 |
| Domain | FN3 | 1.15e-03 | 199 | 194 | 8 | PS50853 | |
| Domain | CADHERIN_1 | 1.17e-03 | 113 | 194 | 6 | PS00232 | |
| Domain | Cadherin | 1.17e-03 | 113 | 194 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 1.22e-03 | 114 | 194 | 6 | PS50268 | |
| Domain | - | 1.22e-03 | 114 | 194 | 6 | 2.60.40.60 | |
| Domain | CA | 1.28e-03 | 115 | 194 | 6 | SM00112 | |
| Domain | Cadherin-like | 1.34e-03 | 116 | 194 | 6 | IPR015919 | |
| Domain | P-loop_NTPase | DHX36 ATP6V1B2 ABCA1 SETX MYO9B SLFN14 TUFM BLM KIF3B MFN2 DDX41 DYNC1H1 ADSS1 RAB31 DDX60 RFC4 DHX30 DNAH1 MTHFD1 | 1.37e-03 | 848 | 194 | 19 | IPR027417 |
| Domain | Cadherin | 1.46e-03 | 118 | 194 | 6 | IPR002126 | |
| Domain | FN3_dom | 1.57e-03 | 209 | 194 | 8 | IPR003961 | |
| Domain | SH3 | 1.93e-03 | 216 | 194 | 8 | SM00326 | |
| Domain | SH3 | 1.93e-03 | 216 | 194 | 8 | PS50002 | |
| Domain | Rab_bind | 2.18e-03 | 7 | 194 | 2 | PF16704 | |
| Domain | GCC2_Rab_bind | 2.18e-03 | 7 | 194 | 2 | IPR032023 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.02e-07 | 12 | 152 | 5 | M27326 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.53e-07 | 14 | 152 | 5 | MM15052 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 4.42e-06 | 62 | 152 | 7 | M11521 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 9.10e-06 | 27 | 152 | 5 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.10e-05 | 28 | 152 | 5 | M924 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | TPM2 NEB SCN7A ANXA1 SLC8A1 AKAP9 ATP2A1 ATP2A2 ATP2A3 ATP2B2 MYBPC3 | 1.24e-05 | 203 | 152 | 11 | M5485 |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA | 6.62e-05 | 8 | 152 | 3 | M47955 | |
| Pathway | KEGG_PYRUVATE_METABOLISM | 6.62e-05 | 40 | 152 | 5 | M7934 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 7.45e-05 | 165 | 152 | 9 | MM15026 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.67e-04 | 76 | 152 | 6 | MM15051 | |
| Pathway | KEGG_HISTIDINE_METABOLISM | 2.50e-04 | 29 | 152 | 4 | M12524 | |
| Pathway | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | 2.52e-04 | 12 | 152 | 3 | MM14908 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.54e-04 | 82 | 152 | 6 | MM15394 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.82e-04 | 54 | 152 | 5 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.82e-04 | 54 | 152 | 5 | MM15202 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 3.29e-04 | 86 | 152 | 6 | M39375 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 3.29e-04 | 86 | 152 | 6 | M916 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | CFH DHX36 ATP6V1B2 TRAF3 ILF2 MYO9B ACLY PECAM1 NFASC NCF2 ITGAV NIT2 PKM PYGL CCR6 C5 DDX41 DYNC1H1 DOCK1 SORBS2 RAB31 CD4 TREM1 | 4.09e-04 | 995 | 152 | 23 | MM14661 |
| Pathway | WP_METABOLIC_EPILEPTIC_DISORDERS | 4.46e-04 | 91 | 152 | 6 | M48079 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 5.15e-04 | 130 | 152 | 7 | M27454 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DHX36 PRPF31 ILF2 ACAT1 CENPF ACLY ETF1 HNRNPM RPS12 NASP KRI1 NDUFA9 CMAS TUFM BLM RBM25 PKM CDC73 PLEC ALDH1B1 DDX41 HSPA4 HSPA9 ANXA1 HNRNPA3 RFC4 CRKL DHX30 CTCF MTHFD1 SUPT16H ATP2A2 | 2.21e-15 | 989 | 199 | 32 | 36424410 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DHX36 ILF2 ACAT1 CENPF NDUFA9 LARP4 CMAS TTC3 PLXNB2 TUFM BLM MIA2 PDCL3 MFN2 ACSF3 ALDH1B1 ALDH3A2 DDX41 HSPA9 MIA3 NAA15 RGPD8 BMP2K NDUFAF2 ATG2B HNRNPA3 RTN4IP1 DHX30 FXR1 AKAP9 NUP155 AASS KIAA1217 SUPT16H PRKCH ATP2A2 SLC33A1 DEPDC1B | 9.10e-15 | 1496 | 199 | 38 | 32877691 |
| Pubmed | DHX36 ILF2 ACAT1 CENPF ACLY RPS12 KRI1 PFKP LARP4 TUFM BLM RBM25 DLD PYGL PLEC HSPA4 HSPA9 DYNC1H1 NAA15 ANXA1 HNRNPA3 DHX30 FXR1 NUP155 CTCF ATP2A2 | 1.01e-14 | 653 | 199 | 26 | 22586326 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | DHX36 ILF2 MYO9B HNRNPM PFKP TUFM RBM25 PKM CDC73 ALDH1B1 ALDH3A2 DDX41 HSPA9 HNRNPA3 RFC4 DHX30 FXR1 MTHFD1 SUPT16H SMARCB1 ATP2A1 ENO2 CWF19L1 | 1.05e-14 | 486 | 199 | 23 | 30940648 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DHX36 ILF2 CAND2 ACLY HNRNPM RPS12 RGPD1 NASP PFKP NDUFA9 TUFM PKM MFN2 DLD PYGL ALDH1B1 CPSF2 ALDH3A2 DDX41 COPS6 HSPA4 HSPA9 DYNC1H1 RGPD5 RGPD8 HNRNPA3 RFC4 DHX30 FXR1 NUP155 MTHFD1 AASS SMARCB1 ATP2A2 | 4.82e-14 | 1257 | 199 | 34 | 37317656 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 DHX36 PRPF31 ILF2 ACAT1 CENPF ACLY ETF1 HNRNPM RPS12 NASP KRI1 CMYA5 TTC3 TUFM RBM25 PKM DLD CDC73 ALDH1B1 ALDH3A2 DDX41 HSPA4 HSPA9 DYNC1H1 MGAM2 HNRNPA3 RFC4 CRKL DHX30 FXR1 NUP155 USO1 MTHFD1 SUPT16H ATP2A2 | 6.03e-14 | 1425 | 199 | 36 | 30948266 |
| Pubmed | DHX36 ATP6V1B2 ILF2 ACAT1 ACLY ETF1 HNRNPM NFASC PFKP NDUFA9 CMAS TUFM ADD1 PKM SYT1 DLD PLEC ALDH1B1 HSPA4 HSPA9 DYNC1H1 SORBS2 KALRN PACSIN1 ANXA1 HNRNPA3 NBEA DHX30 TGM1 FXR1 USO1 MTHFD1 KIAA1217 ATP2A2 ENO2 ATP2B2 | 6.83e-14 | 1431 | 199 | 36 | 37142655 | |
| Pubmed | TRAF3 ILF2 CENPF ETF1 HNRNPM RGPD1 NFASC BTBD9 HCN2 TTC3 ADD1 KIF3B MFN2 SYT1 CDC73 CPSF2 HSPA9 DYNC1H1 MIA3 SORBS2 RGPD8 KALRN NBEA FXR1 AKAP9 CTCF KIAA1217 SUPT16H NT5C2 | 3.11e-13 | 963 | 199 | 29 | 28671696 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX36 PRPF31 ILF2 SETX ACAT1 MYO9B ACLY HNRNPM PFKP NDUFA9 LARP4 CMAS TUFM BLM PKM PYGL PLEC ALDH1B1 DDX41 HSPA4 HSPA9 DYNC1H1 NAA15 ANXA1 HNRNPA3 RFC4 DHX30 TGM1 SMG8 FXR1 NUP155 MTHFD1 SUPT16H ATP2A2 | 3.85e-13 | 1353 | 199 | 34 | 29467282 |
| Pubmed | TPM2 KNTC1 EFCAB5 CENPF HNRNPM RPS12 RGPD1 PFKP NEB TTC3 CHRNA1 TUFM MIA2 SYCP1 PKM DLD PLEC ALDH1B1 HSPA9 RGPD5 AKAP5 RGPD8 PCDHGA7 PCDHGA5 HNRNPA3 KRBA2 STK31 FXR1 KHDRBS3 SCG3 SUPT16H ATP2A1 ATP2A2 ATP2A3 ATP2B2 | 4.47e-13 | 1442 | 199 | 35 | 35575683 | |
| Pubmed | ILF2 TBKBP1 MYO9B HNRNPM RPS12 RGPD1 CMYA5 PFKP NEB TUFM SYCP1 PKM PYGL PLEC ALDH1A3 HSPA9 DYNC1H1 RGPD5 RGPD8 ANXA1 HNRNPA3 KRBA2 CRKL TGM1 HMCN1 MTHFD1 HAL | 5.43e-13 | 844 | 199 | 27 | 25963833 | |
| Pubmed | EFCAB5 CCP110 ACLY HNRNPM KRI1 NEB TUFM SYCP1 PLEC HSPA9 RGPD8 DDX60 FAT3 DHX30 FXR1 SUPT16H | 5.51e-13 | 234 | 199 | 16 | 36243803 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ATP6V1B2 ILF2 ACAT1 RGPD1 NASP PFKP NDUFA9 LARP4 RBM25 DLD PYGL DDX41 HSPA9 DYNC1H1 RGPD8 HNRNPA3 CRKL FXR1 NUP155 USO1 SUPT16H ATP2A1 ATP2A2 ENO2 | 9.38e-13 | 665 | 199 | 24 | 30457570 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DHX36 PRPF31 ILF2 ACLY ETF1 HNRNPM RPS12 KRI1 PFKP NDUFA9 LARP4 TUFM MIA2 PKM CDC73 PLEC DDX41 HSPA4 HSPA9 DYNC1H1 RABGGTB NAA15 ANXA1 HNRNPA3 RFC4 CRKL DHX30 FXR1 NUP155 USO1 MTHFD1 SUPT16H ATP2A2 CWF19L1 | 1.34e-12 | 1415 | 199 | 34 | 28515276 |
| Pubmed | ATP6V1B2 ACAT1 ACLY PFKP NDUFA9 ADD1 PKM SYT1 DLD PLEC HSPA4 HSPA9 DYNC1H1 AKAP5 PACSIN1 SNCB ATP2A2 ENO2 ATP2B2 | 2.59e-12 | 403 | 199 | 19 | 30562941 | |
| Pubmed | ILF2 ACLY ETF1 HNRNPM TUFM ADD1 PKM CDC73 PLEC ALDH3A2 DDX41 HSPA4 HSPA9 DYNC1H1 NAA15 HNRNPA3 DHX30 FXR1 NUP155 USO1 MTHFD1 SUPT16H ATP2A2 | 2.95e-12 | 638 | 199 | 23 | 33239621 | |
| Pubmed | ATP6V1B2 ILF2 ACAT1 ACLY HNRNPM RPS12 PFKP NDUFA9 ITGAV TUFM PKM DLD PLEC ALDH1B1 HSPA9 DYNC1H1 NAA15 BMP2K ANXA1 HNRNPA3 RFC4 DHX30 NUP155 MTHFD1 | 3.40e-12 | 707 | 199 | 24 | 19738201 | |
| Pubmed | DHX36 ATP6V1B2 ILF2 WWC3 MYO9B ACLY ETF1 HNRNPM RPS12 PFKP CMAS TUFM ADD1 RBM25 PKM DLD ALDH1B1 HSPA4 HSPA9 DYNC1H1 ADSS1 WWP1 HNRNPA3 DHX30 DNAH1 FXR1 AKAP9 USO1 CTCF MTHFD1 ATP2A2 | 6.28e-12 | 1247 | 199 | 31 | 27684187 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX36 PRPF31 ILF2 CENPF ACLY ETF1 HNRNPM RPS12 KRI1 PFKP NDUFA9 CMAS TUFM ADD1 RBM25 PKM PLEC DDX41 HSPA9 DYNC1H1 NAA15 ANXA1 DDX60 HNRNPA3 RFC4 DHX30 FXR1 NUP155 MTHFD1 KIAA1217 SUPT16H | 7.69e-12 | 1257 | 199 | 31 | 36526897 |
| Pubmed | EFCAB5 ILF2 TBKBP1 ACAT1 ACLY ETF1 HNRNPM RPS12 NASP KRI1 LARP4 TUFM RBM25 PKM DLD PLEC HSPA4 HSPA9 DYNC1H1 HNRNPA3 RFC4 CRKL DHX30 MTHFD1 EIF1 | 8.88e-12 | 809 | 199 | 25 | 32129710 | |
| Pubmed | TPM2 KIAA0408 CAND2 KLHL41 CMYA5 NEB TTC3 PKM COL14A1 PLEC COPS6 HSPA9 RABGGTB KALRN WWP1 LAMA4 ARHGDIB AKAP9 SUPT16H ATP2A1 | 1.19e-11 | 497 | 199 | 20 | 23414517 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | ATP6V1B2 ACLY KDM5C NFASC PFKP NDUFA9 ADD1 PKM MFN2 SYT1 DLD PYGL HSPA9 DYNC1H1 BMP2K HNRNPA3 SYT2 OGN MTHFD1 ATP2A2 ATP2A3 ATP2B2 | 1.27e-11 | 621 | 199 | 22 | 22794259 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PRPF31 ILF2 CAND2 ACLY HNRNPM RPS12 NASP PFKP TUFM ADD1 PKM PYGL PLEC DDX41 COPS6 HSPA4 HSPA9 DYNC1H1 NAA15 ANXA1 HNRNPA3 RFC4 FXR1 USO1 MTHFD1 SUPT16H EIF1 ATP2A2 ENO2 | 2.27e-11 | 1149 | 199 | 29 | 35446349 |
| Pubmed | EPHB4 ATP6V1B2 ILF2 CAND2 HNRNPM RPS12 KRI1 PFKP NDUFA9 CMAS TTC3 PLXNB2 ADD1 BLM DLD COL14A1 ALDH3A2 HSPA4 HSPA9 FRAS1 MIA3 AKAP5 NAA15 NDUFAF2 RTN4IP1 SNX29 DHX30 AKAP9 NUP155 SUPT16H ATP2A2 SLC33A1 DEPDC1B | 2.46e-11 | 1487 | 199 | 33 | 33957083 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DHX36 PRPF31 ILF2 ACAT1 ACLY ETF1 HNRNPM RPS12 NASP KRI1 NDUFA9 TUFM ADD1 RBM25 PKM DLD PYGL PLEC CPSF2 DDX41 HSPA4 HSPA9 DYNC1H1 BMP2K HNRNPA3 DHX30 FXR1 MTHFD1 SUPT16H SMARCB1 ATP2A2 | 2.53e-11 | 1318 | 199 | 31 | 30463901 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DHX36 PRPF31 ILF2 SETX HNRNPM RPS12 CMAS TUFM BLM RBM25 PKM PLEC CPSF2 DDX41 DYNC1H1 SORBS2 KALRN HNRNPA3 PCDHA1 RFC4 DHX30 KHDRBS3 SCG3 SUPT16H SMARCB1 KDM1B ATP2A2 SPIN3 | 2.93e-11 | 1082 | 199 | 28 | 38697112 |
| Pubmed | ATP6V1B2 ACLY HNRNPM PFKP TUFM KIF3B PKM DLD PLEC HSPA9 DYNC1H1 NAA15 TGM1 FXR1 USO1 MTHFD1 | 4.26e-11 | 312 | 199 | 16 | 37120454 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PRPF31 ATP6V1B2 ILF2 ACAT1 CENPF MYO9B ACLY PFKP PLXNB2 TUFM RBM25 PKM PLEC CPSF2 DDX41 HSPA4 HSPA9 DYNC1H1 ANXA1 HNRNPA3 CRKL DHX30 FXR1 NUP155 MTHFD1 SUPT16H ATP2A2 | 4.50e-11 | 1024 | 199 | 27 | 24711643 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPM2 ILF2 ACLY HNRNPM RPS12 PFKP LARP4 CMAS TUFM RBM25 PKM PLEC DDX41 HSPA9 DYNC1H1 BMP2K ANXA1 HNRNPA3 DHX30 TGM1 FXR1 NUP155 MTHFD1 SUPT16H HAL ATP2A2 | 4.65e-11 | 949 | 199 | 26 | 36574265 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | TPM2 ACLY HNRNPM RBM25 PKM PLEC DYNC1H1 BMP2K ANXA1 ATG2B HNRNPA3 DHX30 MTHFD1 SUPT16H ATP2A2 | 5.18e-11 | 268 | 199 | 15 | 33024031 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ILF2 ACAT1 ACLY ETF1 HNRNPM CLSTN2 PFKP NDUFA9 TUFM PKM DLD PLEC HSPA4 DYNC1H1 MIA3 RAB31 ANXA1 HNRNPA3 DNAH1 AKAP9 MTHFD1 NT5C2 ATP2A1 ATP2A2 | 5.24e-11 | 807 | 199 | 24 | 30575818 |
| Pubmed | ILF2 CENPF ACLY HNRNPM RPS12 PFKP BLM PKM PYGL PLEC HSPA4 HSPA9 NAA15 ANXA1 HNRNPA3 NUP155 USO1 MTHFD1 SUPT16H | 8.57e-11 | 494 | 199 | 19 | 26831064 | |
| Pubmed | DHX36 PRPF31 ILF2 ACLY HNRNPM NASP KRI1 LARP4 TUFM RBM25 CDC73 DDX41 COPS6 HSPA9 FRAS1 NAA15 RFC4 DHX30 FXR1 USO1 CWF19L1 | 2.23e-10 | 653 | 199 | 21 | 33742100 | |
| Pubmed | DHX36 PRPF31 ILF2 ACAT1 ACLY HNRNPM RPS12 CMAS TUFM PKM CPSF2 DDX41 HSPA9 DDX60 HNRNPA3 DHX30 FXR1 MTHFD1 | 2.84e-10 | 469 | 199 | 18 | 37314180 | |
| Pubmed | TPM2 EPHB4 PRPF31 ATP6V1B2 TRAF3 ILF2 SETX ACAT1 ACLY RPS12 PFKP LARP4 ITGAV PLXNB2 MFN2 ALDH3A2 HSPA4 HSPA9 DYNC1H1 RABGGTB MIA3 PIGS HNRNPA3 DHX30 NUP155 MTHFD1 NT5C2 SMARCB1 ATP2A2 | 3.86e-10 | 1297 | 199 | 29 | 33545068 | |
| Pubmed | ATP6V1B2 ILF2 ACAT1 ACLY HNRNPM PFKP CMAS TUFM ADD1 PKM SYT1 DLD HSPA4 HSPA9 DYNC1H1 PACSIN1 ANXA1 HNRNPA3 ENO2 | 5.49e-10 | 552 | 199 | 19 | 36293380 | |
| Pubmed | DHX36 PRPF31 CCP110 ILF2 ACAT1 ACLY EIF1B HNRNPM RPS12 KRI1 CMAS TUFM PKM CDC73 ALDH1B1 DDX41 HSPA4 HSPA9 DYNC1H1 HNRNPA3 RFC4 DHX30 CTCF MTHFD1 SUPT16H EIF1 ENO2 | 6.13e-10 | 1153 | 199 | 27 | 29845934 | |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | PRPF31 ILF2 ACLY HNRNPM RPS12 TUFM PKM ALDH1B1 DYNC1H1 NAA15 RFC4 DHX30 MTHFD1 ATP2A2 | 6.94e-10 | 272 | 199 | 14 | 25315684 |
| Pubmed | DHX36 ACAT1 HNRNPM KRI1 LARP4 ADD1 PLEC CPSF2 DDX41 HSPA4 HSPA9 HNRNPA3 DHX30 FXR1 | 7.63e-10 | 274 | 199 | 14 | 34244482 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPM2 KNTC1 ATP6V1B2 ILF2 ACLY ETF1 HNRNPM RPS12 NASP CMYA5 PFKP TUFM PKM DLD PYGL CDC73 PLEC ALDH1B1 COPS6 HSPA4 HSPA9 DYNC1H1 NAA15 TOM1L1 RFC4 NUP155 MTHFD1 SUPT16H NT5C2 ENO2 | 1.25e-09 | 1455 | 199 | 30 | 22863883 |
| Pubmed | ACLY NCF2 CMAS BLM HSPA4 MIA3 DDX60 HNRNPA3 CRKL FXR1 NUP155 CTCF MTHFD1 ATP2A3 | 1.27e-09 | 285 | 199 | 14 | 32838362 | |
| Pubmed | TPM2 ILF2 SETX ACLY KRI1 LARP4 ITGAV TUFM ADD1 RBM25 PKM COL14A1 C5 PLEC CPSF2 DDX41 HSPA9 DYNC1H1 ANXA1 APOA1 RFC4 FXR1 AKAP9 KHDRBS3 USO1 CTCF SUPT16H SMARCB1 HAL | 1.37e-09 | 1371 | 199 | 29 | 36244648 | |
| Pubmed | ATP6V1B2 ILF2 WWC3 ACLY HNRNPM PFKP TUFM PKM PLEC ALDH3A2 HSPA4 HSPA9 DYNC1H1 NAA15 ANXA1 CEP162 HNRNPA3 FXR1 MTHFD1 ATP2A1 ATP2A2 ENO2 | 1.60e-09 | 803 | 199 | 22 | 36517590 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | ILF2 ACLY HNRNPM PFKP TUFM PKM PYGL ALDH3A2 HSPA4 HSPA9 DYNC1H1 USO1 MTHFD1 ATP2A1 ATP2A2 | 1.64e-09 | 344 | 199 | 15 | 36282215 |
| Pubmed | TPM2 ILF2 ACAT1 MYO9B HNRNPM PFKP TUFM PYGL PLEC DDX41 DYNC1H1 HNRNPA3 DHX30 FXR1 CTCF MTHFD1 SUPT16H ATP2A2 CWF19L1 | 2.22e-09 | 601 | 199 | 19 | 33658012 | |
| Pubmed | DHX36 ILF2 ACAT1 ACLY HNRNPM RPS12 NASP NDUFA9 LARP4 TUFM PKM DLD ALDH1B1 CPSF2 ALDH3A2 COPS6 HSPA4 HSPA9 HNRNPA3 RFC4 CRKL DHX30 FXR1 NUP155 MTHFD1 SUPT16H SMARCB1 ATP2A2 | 3.27e-09 | 1335 | 199 | 28 | 29229926 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | PRPF31 ACLY NASP NDUFA9 RBM25 PKM DLD PYGL HSPA4 DYNC1H1 NAA15 NDUFAF2 ANXA1 FXR1 NT5C2 ATP2A2 | 3.43e-09 | 422 | 199 | 16 | 27342126 |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | PRPF31 ILF2 SETX ACAT1 HNRNPM RPS12 COL6A5 TUFM PLEC HSPA4 HSPA9 DYNC1H1 KRBA2 DHX30 TGM1 HAL ATP2A3 SPIN3 | 4.39e-09 | 558 | 199 | 18 | 27591049 |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | TPM2 ETF1 LARP4 TUFM CDC73 HSPA4 HSPA9 ANXA1 HNRNPA3 RFC4 DHX30 FXR1 KHDRBS3 MTHFD1 | 4.58e-09 | 315 | 199 | 14 | 26777405 |
| Pubmed | PRPF31 ILF2 ACAT1 KDM5C ETF1 PFKP CMAS TUFM NIT2 BLM RBM25 PYGL CDC73 PLEC CPSF2 DDX41 ANXA1 RFC4 NUP155 CTCF SUPT16H SMARCB1 KDM1B CWF19L1 | 4.86e-09 | 1014 | 199 | 24 | 32416067 | |
| Pubmed | ATP6V1B2 ACAT1 ACLY NASP NDUFA9 ITGAV PLXNB2 TUFM NIT2 PKM DLD ALDH1B1 HSPA4 HSPA9 ANXA1 HNRNPA3 LAMA4 MTHFD1 AASS ATP2A1 ATP2A2 ENO2 | 5.46e-09 | 859 | 199 | 22 | 31536960 | |
| Pubmed | ILF2 ACLY ETF1 HNRNPM ADD1 RBM25 PKM ALDH3A2 HSPA4 HSPA9 DYNC1H1 DOCK1 ATG2B FCHO2 CRKL NUP155 USO1 MTHFD1 ATP2A2 DEPDC1B | 5.55e-09 | 708 | 199 | 20 | 39231216 | |
| Pubmed | ILF2 GIPC2 ACAT1 HNRNPM RPS12 TUFM ADD1 PKM PLEC ALDH1B1 CPSF2 ALDH3A2 HSPA9 DYNC1H1 NAA15 HNRNPA3 FXR1 NUP155 SUPT16H ATP2A2 | 5.96e-09 | 711 | 199 | 20 | 33022573 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TPM2 ACLY HNRNPM RPS12 RGPD1 NDUFA9 PKM PYGL ADAM17 PLEC ALDH1B1 HSPA4 HSPA9 DYNC1H1 ANXA1 MTHFD1 ATP2A1 ATP2A2 ATP2A3 | 7.34e-09 | 647 | 199 | 19 | 26618866 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | TPM2 ILF2 ACLY HNRNPM RPS12 NDUFA9 TUFM ADD1 PKM DLD PLEC HSPA4 HSPA9 DYNC1H1 ANXA1 RFC4 DHX30 MTHFD1 | 7.98e-09 | 580 | 199 | 18 | 35676659 |
| Pubmed | ACAT1 CMYA5 NDUFA9 TUFM DLD PLEC ALDH3A2 HSPA9 DYNC1H1 SORBS2 APOA1 RTN4IP1 ATP2A2 MYBPC3 | 8.58e-09 | 331 | 199 | 14 | 29199018 | |
| Pubmed | ACLY HNRNPM NASP CMYA5 PFKP TUFM PKM PYGL HSPA4 HSPA9 NAA15 WWP1 PCDHA4 TGM1 MTHFD1 ENO2 | 8.76e-09 | 451 | 199 | 16 | 36168627 | |
| Pubmed | ACAT1 HNRNPM RGPD1 NDUFA9 CMAS ACSBG1 PKM SYT1 DLD PLEC ALDH1B1 HSPA9 MIA3 SORBS2 NAA15 RGPD8 KALRN ANXA1 ATG2B NBEA CRKL MTHFD1 KIAA1217 SNCB ATP2A2 | 1.01e-08 | 1139 | 199 | 25 | 36417873 | |
| Pubmed | ILF2 HNRNPM RPS12 NASP TUFM PKM PLEC HSPA4 HSPA9 DYNC1H1 ANXA1 MTHFD1 SUPT16H ATP2A3 ENO2 | 1.13e-08 | 397 | 199 | 15 | 21319273 | |
| Pubmed | ILF2 HNRNPM NASP TUFM PKM DLD CDC73 ALDH3A2 HSPA4 HSPA9 DYNC1H1 DHX30 FXR1 NUP155 MTHFD1 ATP2A2 | 1.26e-08 | 463 | 199 | 16 | 34901782 | |
| Pubmed | EIF1B ETF1 RPS12 NASP PFKP SLFN14 TUFM PKM COPS6 HSPA9 NAA15 EIF1 ATP2A2 ATP2A3 ENO2 | 1.79e-08 | 411 | 199 | 15 | 36652389 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ACLY HNRNPM TUFM RBM25 PKM PLEC DDX41 HSPA4 HSPA9 DYNC1H1 HNRNPA3 FXR1 NUP155 MTHFD1 SUPT16H ATP2A2 | 1.91e-08 | 477 | 199 | 16 | 31300519 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | DHRS3 ACLY HNRNPM RPS12 PFKP NDUFA9 ITGAV PLXNB2 TUFM RBM25 PKM DLD ADAM17 PLEC CPSF2 ALDH3A2 HSPA9 BMP2K PIGS HNRNPA3 AKAP9 NUP155 USO1 SUPT16H NT5C2 HAL EIF1 ATP2A2 | 1.95e-08 | 1451 | 199 | 28 | 30550785 |
| Pubmed | 1.99e-08 | 152 | 199 | 10 | 34299191 | ||
| Pubmed | 2.12e-08 | 114 | 199 | 9 | 28245920 | ||
| Pubmed | TPM2 RPS12 TUFM RBM25 PKM PLEC DDX41 HSPA9 ANXA1 APOA1 FXR1 USO1 ATP2A2 | 2.71e-08 | 305 | 199 | 13 | 33194618 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ILF2 HNRNPM NFASC NDUFA9 ITGAV PLXNB2 TUFM ZNF518A BLM MIA2 PKM MFN2 ADAM17 PLEC ALDH3A2 HSPA9 RABGGTB MIA3 BMP2K PIGS HNRNPA3 NUP155 USO1 CTCF ATP2A2 | 2.94e-08 | 1203 | 199 | 25 | 29180619 |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | ILF2 HNRNPM RPS12 PFKP LARP4 TUFM PKM ALDH1B1 HSPA4 HSPA9 DYNC1H1 HNRNPA3 RFC4 FXR1 MTHFD1 ATP2A1 ATP2A2 | 3.31e-08 | 565 | 199 | 17 | 33567341 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | DHX36 PRPF31 ILF2 ACAT1 ACLY HNRNPM LARP4 TUFM PKM CPSF2 HSPA4 HSPA9 DYNC1H1 HNRNPA3 DHX30 FXR1 MTHFD1 SUPT16H SPIN3 | 3.51e-08 | 714 | 199 | 19 | 28302793 |
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | ILF2 ACAT1 ACLY TUFM RBM25 PKM HSPA4 HSPA9 HNRNPA3 FXR1 MTHFD1 ATP2A2 | 3.62e-08 | 258 | 199 | 12 | 21081666 |
| Pubmed | EFCAB5 ATP6V1B2 ILF2 ACAT1 ACLY HNRNPM RPS12 NASP PKM DLD ALDH1B1 HSPA4 HSPA9 DYNC1H1 NAA15 RFC4 NUP155 USO1 MTHFD1 ATP2A2 SLC33A1 | 3.98e-08 | 878 | 199 | 21 | 37223481 | |
| Pubmed | DHX36 HNRNPM RPS12 PFKP TUFM RBM25 PKM DLD PLEC DDX41 HSPA9 HNRNPA3 CRKL DHX30 FXR1 CTCF MTHFD1 ATP2A2 | 5.06e-08 | 655 | 199 | 18 | 35819319 | |
| Pubmed | PRPF31 ILF2 ACLY HNRNPM CMAS TUFM BLM RBM25 PKM HSPA4 HSPA9 HNRNPA3 DHX30 MTHFD1 | 5.31e-08 | 383 | 199 | 14 | 29331416 | |
| Pubmed | PRPF31 SETX HNRNPM PFKP PKM PLEC DYNC1H1 ANXA1 DDX60 HNRNPA3 USO1 ATP2A2 | 6.46e-08 | 272 | 199 | 12 | 31010829 | |
| Pubmed | 7.15e-08 | 8 | 199 | 4 | 10951186 | ||
| Pubmed | 7.62e-08 | 63 | 199 | 7 | 37052853 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | DHX36 ILF2 MYO9B HNRNPM NDUFA9 TTC3 KIF3B MFN2 CDC73 ALDH1B1 DOCK1 HNRNPA3 CRKL DHX30 FXR1 | 8.24e-08 | 462 | 199 | 15 | 31138677 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | TPM2 ETF1 HNRNPM NASP PFKP CMAS PLXNB2 TUFM PKM DLD PYGL COPS6 HSPA4 HSPA9 NAA15 ANXA1 HNRNPA3 RFC4 CRKL TGM1 FXR1 NUP155 USO1 SUPT16H HAL ATP2A2 | 8.76e-08 | 1367 | 199 | 26 | 32687490 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DHX36 PRPF31 ILF2 CENPF MYO9B HNRNPM KRI1 LARP4 CMAS BLM DLD CDC73 ANXA1 HNRNPA3 RFC4 DHX30 FXR1 NUP155 SUPT16H | 9.08e-08 | 759 | 199 | 19 | 35915203 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPM2 KNTC1 ATP6V1B2 ILF2 ETF1 RPS12 NASP PFKP RBM25 DLD PLEC HSPA4 HSPA9 DYNC1H1 MIA3 NAA15 HNRNPA3 KIAA1217 SMARCB1 ENO2 | 1.05e-07 | 847 | 199 | 20 | 35235311 |
| Pubmed | ILF2 ACAT1 HNRNPM PFKP NDUFA9 CMAS ITGAV PLXNB2 TUFM PKM ADAM17 ALDH1B1 COPS6 HSPA9 PIGS NUP155 MTHFD1 | 1.06e-07 | 613 | 199 | 17 | 22268729 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ACLY ETF1 HNRNPM RPS12 NASP PFKP ADD1 PKM DLD ALDH3A2 HSPA4 HSPA9 NAA15 ATG2B RFC4 SNX29 DHX30 CTCF MTHFD1 KIAA1217 DEPDC1B | 1.12e-07 | 934 | 199 | 21 | 33916271 |
| Pubmed | 1.33e-07 | 236 | 199 | 11 | 36339263 | ||
| Pubmed | PRPF31 ILF2 ACLY HNRNPM LARP4 TUFM PKM CDC73 PLEC HSPA4 HSPA9 HNRNPA3 DHX30 FXR1 KHDRBS3 MTHFD1 | 1.38e-07 | 551 | 199 | 16 | 34728620 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | ILF2 HNRNPM RPS12 NDUFA9 TUFM PKM PLEC HSPA4 HSPA9 DYNC1H1 RGPD5 RGPD8 HNRNPA3 DHX30 FXR1 KIAA1217 SUPT16H | 1.43e-07 | 626 | 199 | 17 | 33644029 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PRPF31 ILF2 CAND2 CENPF HNRNPM PFKP CMAS TUFM PKM CDC73 DYNC1H1 RFC4 DHX30 FXR1 USO1 SUPT16H SMARCB1 ATP2A3 | 1.48e-07 | 704 | 199 | 18 | 29955894 |
| Pubmed | ILF2 ACAT1 ACLY ETF1 ADD1 BLM PDCL3 DLD PLEC HSPA4 DYNC1H1 ANXA1 DHX30 USO1 MTHFD1 SUPT16H SMARCB1 ATP2A1 ATP2A2 | 1.55e-07 | 786 | 199 | 19 | 29128334 | |
| Pubmed | 1.61e-07 | 104 | 199 | 8 | 36055981 | ||
| Pubmed | HNRNPM RPS12 ITGAV TUFM RBM25 PKM PLEC DDX41 HSPA9 DYNC1H1 ANXA1 TGM1 MTHFD1 SUPT16H ATP2A2 | 1.67e-07 | 488 | 199 | 15 | 31324722 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | HNRNPM TUFM BLM PKM CDC73 HSPA9 DYNC1H1 HNRNPA3 CRKL TGM1 NUP155 MTHFD1 ATP2A2 | 1.68e-07 | 357 | 199 | 13 | 37059091 |
| Pubmed | DHX36 ILF2 HNRNPM RPS12 LARP4 TUFM PKM HSPA9 HNRNPA3 DHX30 FXR1 KHDRBS3 USO1 MTHFD1 | 1.69e-07 | 421 | 199 | 14 | 34650049 | |
| Pubmed | 1.71e-07 | 191 | 199 | 10 | 33762435 | ||
| Pubmed | 1.80e-07 | 146 | 199 | 9 | 29509794 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 16410239 | ||
| Pubmed | ACLY TUFM PKM CDC73 PLEC HSPA4 HSPA9 DYNC1H1 MIA3 SORBS2 RFC4 USO1 KIAA1217 | 1.85e-07 | 360 | 199 | 13 | 33111431 | |
| Pubmed | PRPF31 ILF2 EIF1B HNRNPM RPS12 NASP KRI1 LARP4 TUFM RBM25 PKM CDC73 CPSF2 ALDH3A2 HSPA4 HSPA9 HNRNPA3 RFC4 DHX30 FXR1 NUP155 | 2.13e-07 | 971 | 199 | 21 | 33306668 | |
| Pubmed | ILF2 CENPF HNRNPM ADD1 SYCP1 PKM DMGDH KALRN FXR1 NUP155 ENO2 MYBPC3 | 2.15e-07 | 304 | 199 | 12 | 32235678 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | KNTC1 PRPF31 CENPF RGPD1 BLM PDCL3 SYCP1 MSL3 PKM ALDH3A2 DDX41 COPS6 DYNC1H1 RGPD5 NAA15 RGPD8 HNRNPA3 APOA1 DHX30 TGM1 NUP155 CTCF SMARCB1 | 2.33e-07 | 1155 | 199 | 23 | 20360068 |
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | 2.63e-07 | 200 | 199 | 10 | 35546148 | |
| Pubmed | ILF2 MYO9B ACLY HNRNPM RPS12 PFKP LARP4 CMAS TUFM KIF3B MIA2 ADAM17 CPSF2 DDX41 DYNC1H1 MIA3 NAA15 PIGS FXR1 NUP155 USO1 MTHFD1 SLC33A1 | 2.84e-07 | 1168 | 199 | 23 | 19946888 | |
| Interaction | STIP1 interactions | ATP6V1B2 ILF2 ACLY ETF1 HNRNPM NASP NEB TUFM ADD1 PKM MFN2 DLD CDC73 PLEC ALDH1B1 ALDH3A2 DDX41 HSPA4 HSPA9 DYNC1H1 NAA15 DDX60 HNRNPA3 DHX30 FXR1 NUP155 USO1 MTHFD1 SUPT16H AKR1B15 ATP2A2 ENO2 HAO2 | 1.01e-09 | 1006 | 198 | 33 | int:STIP1 |
| Interaction | BRD7 interactions | DHX36 ILF2 MYO9B HNRNPM RGPD1 PFKP TUFM RBM25 PKM CDC73 ALDH1B1 ALDH3A2 DDX41 HSPA9 HNRNPA3 LAMA4 RFC4 DHX30 FXR1 MTHFD1 SUPT16H SMARCB1 ATP2A1 ENO2 CWF19L1 | 4.02e-09 | 637 | 198 | 25 | int:BRD7 |
| Interaction | SIRT7 interactions | DHX36 ILF2 ACAT1 CENPF ACLY RPS12 KRI1 PFKP LARP4 TUFM BLM RBM25 DLD PYGL PLEC HSPA4 HSPA9 DYNC1H1 NAA15 ANXA1 HNRNPA3 DHX30 FXR1 NUP155 CTCF ATP2A2 | 2.07e-08 | 744 | 198 | 26 | int:SIRT7 |
| Interaction | KCTD13 interactions | DHX36 ATP6V1B2 ILF2 ACAT1 ACLY ETF1 HNRNPM NFASC BTBD9 PFKP NDUFA9 CMAS TUFM ADD1 PKM SYT1 DLD PLEC ALDH1B1 HSPA4 HSPA9 DYNC1H1 SORBS2 KALRN PACSIN1 ANXA1 HNRNPA3 NBEA DHX30 TGM1 FXR1 USO1 MTHFD1 KIAA1217 ATP2A2 ENO2 ATP2B2 | 2.60e-08 | 1394 | 198 | 37 | int:KCTD13 |
| Interaction | BIRC3 interactions | KNTC1 DHX36 TRAF3 ILF2 ACAT1 CENPF ACLY ETF1 HNRNPM RPS12 NASP KRI1 CMYA5 TTC3 TUFM RBM25 PKM DLD CDC73 ALDH1B1 ALDH3A2 DDX41 HSPA4 HSPA9 DYNC1H1 MGAM2 HNRNPA3 RFC4 CRKL DHX30 FXR1 NUP155 USO1 MTHFD1 SUPT16H ATP2A2 | 2.73e-08 | 1334 | 198 | 36 | int:BIRC3 |
| Interaction | C9orf72 interactions | DHX36 ILF2 CAND2 TBKBP1 ACLY HNRNPM RPS12 RGPD1 NASP PFKP NDUFA9 TUFM PKM MFN2 DLD PYGL ALDH1B1 CPSF2 ALDH3A2 DDX41 COPS6 HSPA4 HSPA9 DYNC1H1 RGPD5 RGPD8 HNRNPA3 RFC4 DHX30 FXR1 NUP155 MTHFD1 AASS SMARCB1 ATP2A2 | 6.66e-08 | 1319 | 198 | 35 | int:C9orf72 |
| Interaction | CIT interactions | DHX36 PRPF31 ILF2 SETX ACAT1 CENPF MYO9B HNRNPM RPS12 KRI1 CMYA5 PFKP TTC3 TUFM BFSP1 RBM25 CDC73 PLEC CPSF2 DDX41 DYNC1H1 SORBS2 KALRN ANXA1 DDX60 HNRNPA3 RFC4 CRKL DHX30 FXR1 AKAP9 NUP155 KHDRBS3 SUPT16H ATP2A1 ATP2A2 SPIN3 | 7.14e-08 | 1450 | 198 | 37 | int:CIT |
| Interaction | MCM2 interactions | ILF2 TBKBP1 MYO9B ACLY HNRNPM RPS12 RGPD1 CMYA5 PFKP NEB TUFM SYCP1 PKM PYGL PLEC ALDH1A3 HSPA9 DYNC1H1 RGPD5 RGPD8 ANXA1 ATG2B HNRNPA3 KRBA2 CRKL DNAH1 TGM1 HMCN1 MTHFD1 SUPT16H HAL | 7.64e-08 | 1081 | 198 | 31 | int:MCM2 |
| Interaction | SHANK3 interactions | TRAF3 TBKBP1 ACAT1 ACLY NFASC HCN2 KIF3B PKM COPS6 DYNC1H1 SORBS2 KALRN PACSIN1 WWP1 CRKL FXR1 KHDRBS3 USO1 SNCB ATP2B2 | 1.04e-07 | 496 | 198 | 20 | int:SHANK3 |
| Interaction | BAP1 interactions | PRPF31 ILF2 CAND2 MYO9B ACLY KDM5C HNRNPM RPS12 MEIOB NASP PFKP TUFM ADD1 PKM PYGL PLEC DDX41 COPS6 HSPA4 HSPA9 DYNC1H1 NAA15 ANXA1 WWP1 HNRNPA3 RFC4 FXR1 USO1 MTHFD1 SUPT16H KDM1B EIF1 ATP2A2 ENO2 | 1.92e-07 | 1314 | 198 | 34 | int:BAP1 |
| Interaction | HTT interactions | ATP6V1B2 ACLY KDM5C HNRNPM NFASC PFKP NDUFA9 ADD1 RBM25 PKM MFN2 SYT1 DLD PYGL PLEC HSPA4 HSPA9 DYNC1H1 BMP2K PACSIN1 HNRNPA3 SYT2 OGN DHX30 MTHFD1 ATP2A2 ATP2A3 ATP2B2 | 1.98e-07 | 949 | 198 | 28 | int:HTT |
| Interaction | PPP1R9B interactions | ATP6V1B2 ACAT1 ACLY PFKP NDUFA9 CMAS ADD1 PKM SYT1 DLD PLEC HSPA4 HSPA9 DYNC1H1 SORBS2 AKAP5 PACSIN1 KIAA1217 SNCB ATP2A2 ENO2 ATP2B2 | 2.51e-07 | 626 | 198 | 22 | int:PPP1R9B |
| Interaction | DVL2 interactions | PRPF31 EIF1B PFKP NEB NDUFA9 TUFM BLM PKM PLEC DDX41 HSPA4 HSPA9 FRAS1 WWP1 RFC4 DENND3 AKAP9 HMCN1 MTHFD1 GAB4 | 6.54e-07 | 557 | 198 | 20 | int:DVL2 |
| Interaction | COPS5 interactions | DHX36 PRPF31 ABCA1 ILF2 CAND2 ACAT1 ETF1 HNRNPM BTBD9 PFKP TTC3 TUFM BLM PKM PYGL ALDH3A2 COPS6 HSPA4 HSPA9 DYNC1H1 HNRNPA3 SYT2 DHX30 FXR1 NUP155 USO1 NT5C2 SMARCB1 EIF1 | 1.23e-06 | 1102 | 198 | 29 | int:COPS5 |
| Interaction | ARHGAP24 interactions | ACAT1 ACLY HNRNPM NASP CMYA5 PFKP TUFM PKM DLD PYGL HSPA4 HSPA9 NAA15 WWP1 PCDHA4 TGM1 MTHFD1 ENO2 | 1.57e-06 | 486 | 198 | 18 | int:ARHGAP24 |
| Interaction | FLT1 interactions | DHX36 ETF1 KRI1 PFKP BLM PDCL3 DYNC1H1 FLT1 CRKL DHX30 NUP155 | 1.64e-06 | 179 | 198 | 11 | int:FLT1 |
| Interaction | RICTOR interactions | DHX36 ATP6V1B2 ACLY HNRNPM RGPD1 NASP PFKP TUFM KIF3B PKM DLD PLEC HSPA4 HSPA9 DYNC1H1 RGPD5 NAA15 RGPD8 ATG2B TGM1 FXR1 USO1 MTHFD1 | 1.72e-06 | 759 | 198 | 23 | int:RICTOR |
| Interaction | TNIP1 interactions | TPM2 TRAF3 ILF2 ACLY HNRNPM RPS12 PFKP LARP4 CMAS TUFM BFSP1 RBM25 PKM PLEC DDX41 HSPA9 DYNC1H1 BMP2K ANXA1 HNRNPA3 LAMA4 DHX30 TGM1 FXR1 NUP155 MTHFD1 SUPT16H HAL ATP2A2 HAO2 | 2.99e-06 | 1217 | 198 | 30 | int:TNIP1 |
| Interaction | UFL1 interactions | DHX36 PRPF31 ILF2 ACAT1 ACLY HNRNPM RPS12 CMAS TUFM RBM25 PKM DLD CDC73 CPSF2 ALDH3A2 DDX41 HSPA9 HNRNPA3 RFC4 DHX30 FXR1 NUP155 MTHFD1 SUPT16H ATP2A1 ATP2A2 CWF19L1 | 3.27e-06 | 1031 | 198 | 27 | int:UFL1 |
| Interaction | WDR5 interactions | PRPF31 ATP6V1B2 TRAF3 ILF2 GIPC2 ACAT1 ACLY HNRNPM RPS12 TUFM ADD1 PKM PLEC ALDH1B1 CPSF2 ALDH3A2 HSPA4 HSPA9 DYNC1H1 NAA15 HNRNPA3 FXR1 NUP155 CTCF SUPT16H SMARCB1 KDM1B ATP2A2 | 3.69e-06 | 1101 | 198 | 28 | int:WDR5 |
| Interaction | GLDC interactions | DHX36 ACAT1 HNRNPM KRI1 LARP4 ADD1 PLEC CPSF2 DDX41 HSPA4 HSPA9 HNRNPA3 DHX30 FXR1 | 3.75e-06 | 321 | 198 | 14 | int:GLDC |
| Interaction | ZNF746 interactions | PRPF31 ILF2 ACLY HNRNPM RPS12 TUFM PKM ALDH1B1 DYNC1H1 NAA15 RFC4 DHX30 MTHFD1 ATP2A2 | 4.48e-06 | 326 | 198 | 14 | int:ZNF746 |
| Interaction | CEBPB interactions | DHX36 ILF2 GIPC2 ACAT1 ACLY ETF1 HNRNPM RPS12 NASP TUFM RBM25 PKM DLD PYGL C5 CDC73 PLEC ALDH1B1 DDX41 HSPA4 HSPA9 DYNC1H1 NAA15 NDUFAF2 ANXA1 HNRNPA3 RFC4 AKAP9 USO1 CTCF MTHFD1 SUPT16H SMARCB1 | 4.51e-06 | 1443 | 198 | 33 | int:CEBPB |
| Interaction | KIF20A interactions | TPM2 ILF2 SETX TBKBP1 HNRNPM RPS12 NDUFA9 TUFM BLM RBM25 MIA2 ACSBG1 PKM PLEC ALDH1B1 CPSF2 RGPD8 HNRNPA3 CRKL DHX30 FXR1 NUP155 KHDRBS3 SUPT16H SMARCB1 SNCB ATP2A1 | 4.75e-06 | 1052 | 198 | 27 | int:KIF20A |
| Interaction | CYLD interactions | PRPF31 TRAF3 ILF2 SETX ACAT1 ACLY HNRNPM RPS12 COL6A5 TUFM PLEC HSPA4 HSPA9 DYNC1H1 KRBA2 RFC4 CRKL DHX30 TGM1 MTHFD1 HAL KDM1B ATP2A3 SPIN3 | 4.88e-06 | 868 | 198 | 24 | int:CYLD |
| Interaction | PHLPP1 interactions | CENPF ACLY NASP KRI1 CMYA5 NEB PKM DLD PLEC DYNC1H1 ATG2B FCHO2 KIAA1217 DEPDC1B | 5.71e-06 | 333 | 198 | 14 | int:PHLPP1 |
| Interaction | TRPV1 interactions | 5.99e-06 | 131 | 198 | 9 | int:TRPV1 | |
| Interaction | LATS1 interactions | PRPF31 CCP110 WWC3 RGPD1 NEB CMAS PLEC CPSF2 MIA3 WWP1 STK31 AKAP9 KIAA1217 HAL ATP2A1 SPIN3 | 7.71e-06 | 440 | 198 | 16 | int:LATS1 |
| Interaction | ISG15 interactions | TPM2 ACLY HNRNPM NIT2 RBM25 PKM PLEC ALDH1A3 HSPA4 DYNC1H1 BMP2K ANXA1 HNRNPA3 DHX30 MTHFD1 SUPT16H ATP2A2 | 8.20e-06 | 494 | 198 | 17 | int:ISG15 |
| Interaction | G3BP1 interactions | TPM2 DHX36 CENPF ETF1 RPS12 KRI1 LARP4 TUFM DLD CDC73 ALDH3A2 HSPA4 HSPA9 DYNC1H1 ANXA1 HNRNPA3 RFC4 DHX30 FXR1 NUP155 KHDRBS3 MTHFD1 ATP2A2 | 8.30e-06 | 835 | 198 | 23 | int:G3BP1 |
| Interaction | PFKL interactions | PFKP PKM PYGL COPS6 HSPA9 FLT1 CEP162 DDX60 HNRNPA3 TEK MTHFD1 | 9.16e-06 | 214 | 198 | 11 | int:PFKL |
| Interaction | USP48 interactions | ATP6V1B2 ILF2 ACAT1 ACLY HNRNPM PFKP CMAS TUFM ADD1 PKM SYT1 DLD HSPA4 HSPA9 DYNC1H1 RABGGTB PACSIN1 ANXA1 HNRNPA3 ENO2 | 1.01e-05 | 668 | 198 | 20 | int:USP48 |
| Interaction | FN1 interactions | ATP6V1B2 ILF2 ACLY HNRNPM RPS12 PFKP NDUFA9 ITGAV TUFM PKM DLD PLEC ALDH1B1 HSPA9 DYNC1H1 NAA15 BMP2K ANXA1 HNRNPA3 APOA1 RFC4 DHX30 NUP155 | 1.06e-05 | 848 | 198 | 23 | int:FN1 |
| Interaction | EFTUD2 interactions | DHX36 PRPF31 ILF2 ACLY ETF1 HNRNPM RPS12 KRI1 PFKP NDUFA9 LARP4 TUFM PKM CDC73 PLEC CPSF2 COPS6 HSPA4 HSPA9 DYNC1H1 NAA15 ANXA1 HNRNPA3 RFC4 CRKL DHX30 FXR1 NUP155 MTHFD1 SUPT16H NT5C2 SMARCB1 | 1.31e-05 | 1449 | 198 | 32 | int:EFTUD2 |
| Interaction | HDAC6 interactions | TPM2 ILF2 ACLY KDM5C HNRNPM RPS12 NASP PFKP NDUFA9 TUFM ADD1 ZNF518A PKM MFN2 DLD PLEC DDX41 HSPA4 HSPA9 DYNC1H1 ANXA1 RFC4 DHX30 MTHFD1 | 1.51e-05 | 929 | 198 | 24 | int:HDAC6 |
| Interaction | CHMP4C interactions | ILF2 ACLY EIF1B HNRNPM RPS12 NASP KRI1 PFKP TUFM RBM25 PKM HSPA4 HSPA9 ANXA1 CEP162 HNRNPA3 DHX30 FXR1 NUP155 SUPT16H | 1.52e-05 | 687 | 198 | 20 | int:CHMP4C |
| Interaction | GSK3B interactions | DHX36 CCP110 ACLY HNRNPM RGPD1 KRI1 NDUFA9 ADD1 ACSBG1 PKM PYGL PLEC ALDH1A3 HSPA4 HSPA9 MIA3 ANXA1 ATG2B SNX29 FXR1 USO1 MTHFD1 PLEKHO1 | 1.54e-05 | 868 | 198 | 23 | int:GSK3B |
| Interaction | MOB3C interactions | DHX36 ACLY NASP MIA2 PKM HSPA4 DYNC1H1 MIA3 ANXA1 RFC4 NUP155 USO1 MTHFD1 NT5C2 | 1.56e-05 | 364 | 198 | 14 | int:MOB3C |
| Interaction | AGR2 interactions | ILF2 ACAT1 ACLY ETF1 HNRNPM CLSTN2 PFKP NDUFA9 TUFM PKM DLD PLEC HSPA4 DYNC1H1 MIA3 RAB31 ANXA1 HNRNPA3 DNAH1 AKAP9 MTHFD1 NT5C2 ATP2A1 ATP2A2 | 1.65e-05 | 934 | 198 | 24 | int:AGR2 |
| Interaction | TRAP1 interactions | ACAT1 ACLY PKM DLD PYGL ALDH1B1 HSPA9 DYNC1H1 FLT1 NDUFAF2 RTN4IP1 CRKL DHX30 FXR1 AASS ENO2 | 1.65e-05 | 468 | 198 | 16 | int:TRAP1 |
| Interaction | NR2C2 interactions | DHX36 PRPF31 ILF2 ACAT1 ACLY ETF1 HNRNPM RPS12 NASP KRI1 NDUFA9 TUFM ADD1 RBM25 PKM DLD PYGL PLEC CPSF2 DDX41 HSPA4 HSPA9 DYNC1H1 BMP2K HNRNPA3 DHX30 FXR1 MTHFD1 SUPT16H SMARCB1 ATP2A2 | 1.80e-05 | 1403 | 198 | 31 | int:NR2C2 |
| Interaction | ECT2 interactions | TPM2 DHX36 ILF2 ACLY HNRNPM RPS12 KRI1 CMYA5 TUFM BLM PKM PLEC ALDH1B1 CPSF2 ALDH3A2 DYNC1H1 HNRNPA3 RFC4 DHX30 NUP155 SUPT16H ATP2A1 ATP2A2 | 2.17e-05 | 887 | 198 | 23 | int:ECT2 |
| Interaction | IFI16 interactions | DHX36 PRPF31 ILF2 ACLY HNRNPM KRI1 LARP4 ADD1 RBM25 PKM DDX41 HSPA4 HSPA9 RGPD8 DHX30 FXR1 KHDRBS3 CTCF SUPT16H SPIN3 | 2.64e-05 | 714 | 198 | 20 | int:IFI16 |
| Interaction | PRPF8 interactions | PRPF31 ABCA1 ILF2 HNRNPM RPS12 NDUFA9 PKM PLEC DDX41 HSPA4 HSPA9 DYNC1H1 ANXA1 HNRNPA3 CRKL DHX30 NUP155 MTHFD1 SUPT16H NT5C2 CWF19L1 | 2.73e-05 | 776 | 198 | 21 | int:PRPF8 |
| Interaction | VCP interactions | TPM2 EPHB4 KNTC1 PRPF31 ACAT1 ACLY NASP NEB NDUFA9 CMAS TUFM ADD1 BLM RBM25 PKM MFN2 DLD CDC73 PLEC ALDH3A2 HSPA4 DYNC1H1 TOM1L1 APOA1 NBEA FXR1 CD4 USO1 AASS SUPT16H ATP2A2 | 2.78e-05 | 1435 | 198 | 31 | int:VCP |
| Interaction | PXN interactions | KNTC1 CCP110 TBKBP1 ITGAV ADAM17 HSPA4 HSPA9 RABGGTB MIA3 SORBS2 CRKL AKAP9 KIAA1217 | 2.79e-05 | 334 | 198 | 13 | int:PXN |
| Interaction | METTL3 interactions | PRPF31 ILF2 ACAT1 HNRNPM PFKP TUFM COL14A1 HSPA4 HSPA9 ANXA1 HNRNPA3 KHDRBS3 | 2.84e-05 | 287 | 198 | 12 | int:METTL3 |
| Interaction | CDK2 interactions | TPM2 CCP110 ILF2 HNRNPM RPS12 NASP TUFM PKM PLEC COPS6 HSPA4 HSPA9 DYNC1H1 BMP2K ANXA1 RFC4 MTHFD1 SUPT16H PRKCH ATP2A3 ENO2 | 3.11e-05 | 783 | 198 | 21 | int:CDK2 |
| Interaction | EED interactions | KNTC1 DHX36 ILF2 SETX CAND2 ACLY ETF1 HNRNPM RPS12 PLXNB2 TUFM RBM25 PKM ADAM17 PLEC CPSF2 DDX41 HSPA9 DYNC1H1 RAB31 NAA15 BMP2K HNRNPA3 RFC4 FXR1 NUP155 USO1 CTCF MTHFD1 SUPT16H ATP2A2 | 3.18e-05 | 1445 | 198 | 31 | int:EED |
| Interaction | ATXN1 interactions | ATP6V1B2 ILF2 ACAT1 EIF1B NASP PFKP NDUFA9 LARP4 RBM25 DLD PYGL DDX41 HSPA4 HSPA9 DYNC1H1 HNRNPA3 STK31 CRKL FXR1 NUP155 USO1 SUPT16H ATP2A1 ATP2A2 ENO2 | 3.24e-05 | 1039 | 198 | 25 | int:ATXN1 |
| Interaction | PIH1D1 interactions | ILF2 ACLY HNRNPM RPS12 PFKP NDUFA9 MIA2 PKM MFN2 PLEC DDX41 HSPA4 HSPA9 DYNC1H1 HNRNPA3 CRKL DHX30 NUP155 USO1 MTHFD1 | 3.67e-05 | 731 | 198 | 20 | int:PIH1D1 |
| Interaction | SYCE1 interactions | 3.72e-05 | 127 | 198 | 8 | int:SYCE1 | |
| Interaction | USP25 interactions | 3.72e-05 | 127 | 198 | 8 | int:USP25 | |
| Interaction | DDRGK1 interactions | PRPF31 ILF2 CAND2 ACAT1 TNFSF9 HNRNPM RPS12 KRI1 LARP4 CMAS TUFM RBM25 PKM DLD CDC73 ALDH3A2 DDX41 HSPA4 HSPA9 HNRNPA3 RFC4 DHX30 FXR1 NUP155 CTCF SUPT16H ATP2A1 ATP2A2 | 3.73e-05 | 1249 | 198 | 28 | int:DDRGK1 |
| Interaction | HECTD1 interactions | TPM2 DHX36 PRPF31 ILF2 CENPF MYO9B HNRNPM KRI1 LARP4 CMAS BLM RBM25 DLD CDC73 CPSF2 DDX41 HSPA4 ANXA1 HNRNPA3 RFC4 DHX30 FXR1 NUP155 SUPT16H | 3.81e-05 | 984 | 198 | 24 | int:HECTD1 |
| Interaction | FGD5 interactions | 3.99e-05 | 207 | 198 | 10 | int:FGD5 | |
| Interaction | PINK1 interactions | TRAF3 ACLY HNRNPM TUFM RBM25 PKM MFN2 PLEC DDX41 HSPA4 HSPA9 DYNC1H1 HNRNPA3 TGM1 FXR1 NUP155 MTHFD1 SUPT16H ATP2A2 | 4.29e-05 | 679 | 198 | 19 | int:PINK1 |
| Interaction | PAGE4 interactions | DHX36 PRPF31 ILF2 ACLY HNRNPM NASP TUFM PKM HSPA9 DYNC1H1 ATP2A1 | 4.32e-05 | 253 | 198 | 11 | int:PAGE4 |
| Interaction | FNDC5 interactions | DHRS3 ACLY HNRNPM RPS12 PFKP NDUFA9 ITGAV PLXNB2 TUFM RBM25 PKM DLD ADAM17 PLEC CPSF2 HSPA9 BMP2K PIGS HNRNPA3 APOA1 PCDHA4 TGM1 AKAP9 NUP155 USO1 SUPT16H NT5C2 HAL EIF1 ATP2A2 ATP2A3 | 4.40e-05 | 1470 | 198 | 31 | int:FNDC5 |
| Interaction | EIF2B2 interactions | 4.65e-05 | 131 | 198 | 8 | int:EIF2B2 | |
| Interaction | KCNA3 interactions | ILF2 ACLY ETF1 HNRNPM ADD1 RBM25 PKM PYGL ALDH3A2 HSPA4 HSPA9 DYNC1H1 DOCK1 CCDC73 ATG2B FCHO2 CRKL NUP155 USO1 MTHFD1 ATP2A2 DEPDC1B | 4.91e-05 | 871 | 198 | 22 | int:KCNA3 |
| Interaction | WWOX interactions | DHX36 PRPF31 TRAF3 ACLY PKM DLD ALDH1B1 CPSF2 ALDH3A2 HSPA4 MIA3 ANXA1 HNRNPA3 RFC4 DHX30 NUP155 ATP2A1 ATP2A2 | 4.95e-05 | 627 | 198 | 18 | int:WWOX |
| Interaction | PDHA1 interactions | ILF2 ACAT1 NDUFA9 TUFM ADD1 ACSF3 DLD PLEC ALDH1B1 HSPA9 DYNC1H1 NAA15 NDUFAF2 RTN4IP1 DHX30 USO1 AASS SUPT16H ATP2A1 ATP2A2 | 5.24e-05 | 750 | 198 | 20 | int:PDHA1 |
| Interaction | SLX4 interactions | HNRNPM NDUFA9 TUFM ZNF518A BLM PKM CDC73 HSPA9 DYNC1H1 HNRNPA3 CRKL DHX30 TGM1 NUP155 MTHFD1 SUPT16H ATP2A2 | 5.28e-05 | 572 | 198 | 17 | int:SLX4 |
| Interaction | PRKACA interactions | ABCA1 ACLY HNRNPM NASP LARP4 ADD1 HSPA4 HSPA9 DYNC1H1 DOCK1 AKAP5 ANXA1 AKAP9 USO1 DEPDC1B MYBPC3 | 5.74e-05 | 519 | 198 | 16 | int:PRKACA |
| Interaction | FBXW7 interactions | TPM2 ILF2 ACAT1 MYO9B ACLY HNRNPM ZSWIM2 PFKP ITGAV TUFM BLM PYGL PLEC DDX41 COPS6 HSPA9 DYNC1H1 ANXA1 HNRNPA3 DHX30 FXR1 CTCF MTHFD1 SUPT16H AKR1B15 ATP2A2 CWF19L1 | 6.05e-05 | 1215 | 198 | 27 | int:FBXW7 |
| Interaction | MECP2 interactions | DHX36 PRPF31 ILF2 SETX HNRNPM RPS12 CMAS TUFM BLM RBM25 PKM PLEC CPSF2 DDX41 DYNC1H1 SORBS2 KALRN HNRNPA3 PCDHA1 RFC4 DHX30 KHDRBS3 SCG3 SUPT16H SMARCB1 KDM1B ATP2A2 SPIN3 | 6.30e-05 | 1287 | 198 | 28 | int:MECP2 |
| Interaction | PSMD14 interactions | PRPF31 ILF2 SETX GIPC2 ACLY HNRNPM KRI1 CMYA5 FMN1 PKM PLEC COPS6 HSPA4 HSPA9 KHDRBS3 NT5C2 | 6.87e-05 | 527 | 198 | 16 | int:PSMD14 |
| Interaction | KRT18 interactions | KNTC1 CCP110 ACLY BBS4 TUFM PKM PLEC ALDH3A2 HSPA4 CEP162 FXR1 CD4 CTCF KIAA1217 | 7.22e-05 | 419 | 198 | 14 | int:KRT18 |
| Interaction | RUFY1 interactions | ILF2 ACLY HNRNPM PFKP TUFM PKM PYGL ALDH3A2 HSPA4 HSPA9 DYNC1H1 USO1 MTHFD1 ATP2A1 ATP2A2 | 7.70e-05 | 476 | 198 | 15 | int:RUFY1 |
| Interaction | KIF23 interactions | DHX36 ILF2 MYO9B ACLY HNRNPM RPS12 KRI1 NDUFA9 LARP4 TUFM RBM25 PLEC ALDH3A2 DDX41 DYNC1H1 ANXA1 HNRNPA3 RFC4 CRKL DHX30 FXR1 NUP155 SUPT16H ATP2A2 | 7.91e-05 | 1031 | 198 | 24 | int:KIF23 |
| Interaction | KCTD9 interactions | ILF2 ACLY HNRNPM PKM PYGL COPS6 HSPA4 DYNC1H1 MTHFD1 SMARCB1 | 8.04e-05 | 225 | 198 | 10 | int:KCTD9 |
| Interaction | OBSL1 interactions | PRPF31 ILF2 TBKBP1 CENPF ACLY LARP4 TUFM RBM25 PKM PLEC CPSF2 DDX41 HSPA9 DYNC1H1 MGAM2 ANXA1 HNRNPA3 SNX29 DHX30 DNAH1 NUP155 SUPT16H | 8.19e-05 | 902 | 198 | 22 | int:OBSL1 |
| Interaction | RHOB interactions | EPHB4 ILF2 ACAT1 MYO9B RPS12 PFKP ITGAV PLXNB2 ALDH1B1 HSPA9 DOCK1 AKAP5 NDUFAF2 NBEA FCHO2 SNX29 DHX30 NUP155 SUPT16H PRKCH DEPDC1B | 8.49e-05 | 840 | 198 | 21 | int:RHOB |
| Interaction | FBXO43 interactions | 8.87e-05 | 74 | 198 | 6 | int:FBXO43 | |
| Interaction | USP7 interactions | KIAA0408 EFCAB5 CCP110 ABCA1 TRAF3 DHRS3 ACLY HNRNPM KRI1 NEB BRWD3 SYCP1 MSL3 PKM PLEC COPS6 HSPA9 DYNC1H1 RGPD8 ANXA1 DDX60 FAT3 STK31 CRKL DHX30 FXR1 SUPT16H PLEKHO1 | 8.89e-05 | 1313 | 198 | 28 | int:USP7 |
| Interaction | CUL7 interactions | ILF2 ACAT1 CENPF ACLY PFKP TUFM RBM25 PKM PLEC HSPA9 DYNC1H1 ANXA1 HNRNPA3 APOA1 SYT2 CRKL FXR1 NUP155 MTHFD1 SUPT16H ATP2A2 | 9.23e-05 | 845 | 198 | 21 | int:CUL7 |
| Interaction | PCDHGA7 interactions | 9.73e-05 | 25 | 198 | 4 | int:PCDHGA7 | |
| Interaction | HDAC5 interactions | ILF2 ACAT1 ACLY TUFM RBM25 PKM HSPA4 HSPA9 ANXA1 HNRNPA3 FXR1 MTHFD1 ATP2A2 ENO2 | 9.98e-05 | 432 | 198 | 14 | int:HDAC5 |
| Interaction | EP300 interactions | CFH DHX36 PRPF31 ILF2 ACLY HNRNPM NASP KRI1 LARP4 ITGAV TUFM RBM25 PKM CDC73 DDX41 COPS6 HSPA9 FRAS1 NAA15 RFC4 DHX30 FXR1 USO1 CTCF SUPT16H SMARCB1 ATP2A2 SLC33A1 CWF19L1 | 1.11e-04 | 1401 | 198 | 29 | int:EP300 |
| Interaction | BTF3 interactions | ILF2 HNRNPM RPS12 NDUFA9 CMAS TUFM PKM CDC73 PLEC HSPA4 HSPA9 DYNC1H1 RGPD5 NAA15 RGPD8 HNRNPA3 DHX30 FXR1 KIAA1217 SUPT16H | 1.24e-04 | 799 | 198 | 20 | int:BTF3 |
| Interaction | RECQL4 interactions | DHX36 ILF2 ACAT1 ACLY HNRNPM RPS12 NASP NDUFA9 LARP4 TUFM PKM DLD PLEC ALDH1B1 CPSF2 ALDH3A2 COPS6 HSPA4 HSPA9 HNRNPA3 RFC4 CRKL DHX30 FXR1 NUP155 MTHFD1 SUPT16H SMARCB1 ATP2A2 | 1.27e-04 | 1412 | 198 | 29 | int:RECQL4 |
| Interaction | NPM1 interactions | DHX36 CENPF MYO9B EIF1B HNRNPM RPS12 KRI1 NEB LARP4 CMAS TUFM SYCP1 PKM CPSF2 COPS6 HSPA4 HSPA9 AKAP5 NAA15 WWP1 RFC4 DHX30 FXR1 CD4 CTCF SUPT16H | 1.28e-04 | 1201 | 198 | 26 | int:NPM1 |
| Interaction | RHOBTB1 interactions | 1.32e-04 | 152 | 198 | 8 | int:RHOBTB1 | |
| Interaction | TNF interactions | TPM2 TRAF3 TBKBP1 TNFSF9 HNRNPM RPS12 TUFM PKM ADAM17 PLEC HNRNPA3 PLEKHO1 | 1.44e-04 | 340 | 198 | 12 | int:TNF |
| Interaction | CDK9 interactions | TPM2 ILF2 HNRNPM LARP4 ADD1 RBM25 PKM DLD CDC73 PLEC ALDH1B1 HSPA9 HNRNPA3 RFC4 NUP155 SUPT16H SMARCB1 ATP2A2 | 1.51e-04 | 685 | 198 | 18 | int:CDK9 |
| Interaction | CFD interactions | DHRS3 ACLY HNRNPM RPS12 PFKP NDUFA9 ITGAV PLXNB2 TUFM RBM25 PKM DLD ADAM17 PLEC CPSF2 HSPA9 BMP2K PIGS HNRNPA3 PCDHA4 AKAP9 NUP155 USO1 SUPT16H NT5C2 HAL EIF1 ATP2A2 | 1.61e-04 | 1360 | 198 | 28 | int:CFD |
| Interaction | TRIM31 interactions | DHX36 ILF2 HNRNPM RPS12 LARP4 TUFM PKM HSPA9 HNRNPA3 DHX30 FXR1 KHDRBS3 USO1 MTHFD1 | 1.67e-04 | 454 | 198 | 14 | int:TRIM31 |
| Interaction | RNF113A interactions | DHX36 HNRNPM RPS12 PFKP TUFM RBM25 PKM DLD PLEC DDX41 HSPA9 HNRNPA3 CRKL DHX30 FXR1 CTCF MTHFD1 ATP2A2 | 1.71e-04 | 692 | 198 | 18 | int:RNF113A |
| Interaction | TNIP2 interactions | ATP6V1B2 ILF2 ACAT1 MYO9B ACLY EIF1B HNRNPM RPS12 BTBD9 TUFM PKM CPSF2 HSPA4 WWP1 HNRNPA3 LAMA4 TEK DHX30 MTHFD1 SUPT16H RAB11FIP4 EIF1 | 1.77e-04 | 952 | 198 | 22 | int:TNIP2 |
| Interaction | FUS interactions | ABCA1 ILF2 ACAT1 HNRNPM PFKP TUFM RBM25 PKM DLD CDC73 CPSF2 COPS6 HSPA9 DYNC1H1 HNRNPA3 DHX30 KHDRBS3 MTHFD1 SMARCB1 | 1.78e-04 | 757 | 198 | 19 | int:FUS |
| Interaction | ST8SIA4 interactions | 1.79e-04 | 84 | 198 | 6 | int:ST8SIA4 | |
| Interaction | ATG16L1 interactions | CCP110 ILF2 TBKBP1 WWC3 ACAT1 EIF1B RPS12 CCDC168 PFKP TUFM PKM SYT1 PLEC CPSF2 HSPA4 HSPA9 RGPD5 ATG2B SNX29 FXR1 KIAA1217 SUPT16H NT5C2 DEPDC1B CWF19L1 | 1.89e-04 | 1161 | 198 | 25 | int:ATG16L1 |
| Interaction | LRRC31 interactions | 2.00e-04 | 205 | 198 | 9 | int:LRRC31 | |
| Interaction | ENO1 interactions | CENPF HNRNPM NEB NIT2 RBM25 SYCP1 PKM COL14A1 CDC73 HSPA9 DYNC1H1 ANXA1 DHX30 FXR1 CD4 SCG3 AKR1B15 ENO2 | 2.01e-04 | 701 | 198 | 18 | int:ENO1 |
| Interaction | RIN3 interactions | ILF2 HNRNPM RPS12 PKM PLEC ALDH3A2 HSPA4 HSPA9 DYNC1H1 RAB31 CRKL TGM1 FXR1 ATP2A2 | 2.05e-04 | 463 | 198 | 14 | int:RIN3 |
| Interaction | NEK4 interactions | PRPF31 ILF2 HNRNPM RPS12 NEB TUFM BLM PKM HSPA9 FRAS1 RGPD8 CEP162 ATG2B HNRNPA3 KIAA1217 ATP2A3 | 2.14e-04 | 582 | 198 | 16 | int:NEK4 |
| Interaction | NFX1 interactions | DHX36 ILF2 HNRNPM RPS12 LARP4 PKM HSPA4 HSPA9 HNRNPA3 RFC4 DHX30 TGM1 FXR1 MTHFD1 | 2.19e-04 | 466 | 198 | 14 | int:NFX1 |
| Interaction | ACE2 interactions | ATP6V1B2 ILF2 ACAT1 ACLY HNRNPM RPS12 KRI1 PFKP LARP4 TUFM RBM25 PKM ADAM17 PLEC HSPA4 DYNC1H1 HNRNPA3 NBEA CRKL DHX30 NUP155 MTHFD1 SUPT16H ATP2A2 | 2.29e-04 | 1106 | 198 | 24 | int:ACE2 |
| Interaction | MECOM interactions | TPM2 PFKP NEB NDUFA9 TUFM PKM PLEC ALDH1B1 DYNC1H1 SUPT16H ATP2A1 ATP2A2 | 2.31e-04 | 358 | 198 | 12 | int:MECOM |
| GeneFamily | ATPases Ca2+ transporting | 3.64e-07 | 9 | 135 | 4 | 1209 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.48e-05 | 115 | 135 | 7 | 769 | |
| GeneFamily | Fibronectin type III domain containing | 2.70e-05 | 160 | 135 | 8 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.83e-05 | 161 | 135 | 8 | 593 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 6.11e-05 | 29 | 135 | 4 | 396 | |
| GeneFamily | Aldehyde dehydrogenases | 3.61e-04 | 19 | 135 | 3 | 398 | |
| GeneFamily | Clustered protocadherins | 1.34e-03 | 64 | 135 | 4 | 20 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.29e-03 | 40 | 135 | 3 | 321 | |
| GeneFamily | Immunoglobulin like domain containing | 3.30e-03 | 193 | 135 | 6 | 594 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | KNTC1 CCP110 CENPF NASP NFASC TTC3 BLM PKM SYT1 HNRNPA3 NBEA SYT2 RFC4 SLC8A1 NUP155 ZNF382 SCG3 SUPT16H NT5C2 SNCB DEPDC1B | 6.02e-08 | 680 | 199 | 21 | MM456 |
| Coexpression | LINDSTEDT_DENDRITIC_CELL_MATURATION_D | 8.42e-06 | 63 | 199 | 6 | M3848 | |
| Coexpression | HEVNER_CORTEX_VASCULAR_ENDOTHELIAL_CELLS | 1.14e-05 | 19 | 199 | 4 | MM420 | |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP | 2.01e-05 | 196 | 199 | 9 | M3351 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 2.30e-05 | 250 | 199 | 10 | M11318 | |
| Coexpression | GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP | 2.36e-05 | 200 | 199 | 9 | M7020 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN | 2.36e-05 | 200 | 199 | 9 | M5135 | |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN | 2.36e-05 | 200 | 199 | 9 | M5590 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | EPHB4 KNTC1 DHX36 CCP110 NASP PFKP LARP4 DLD FRAS1 NAA15 RFC4 NUP155 CTCF MTHFD1 KDM1B | 2.43e-05 | 555 | 199 | 15 | M2343 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | TPM2 CFH WWC3 PECAM1 ANKRD20A8P SCN7A COL14A1 ALDH1A3 FLT1 MXRA5 ANXA1 LAMA4 TEK CD4 | 3.46e-05 | 505 | 199 | 14 | M39167 |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | CFH ILF2 EIF1B ETF1 HNRNPM NASP RBM25 HSPA9 NAA15 HNRNPA3 LAMA4 OGN | 3.67e-05 | 380 | 199 | 12 | M41703 |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 3.81e-05 | 164 | 199 | 8 | M19957 | |
| Coexpression | TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL | ATP6V1B2 ABCA1 EIF1B ETF1 HNRNPM NCF2 ITGAV FMN1 PKM ADAM17 PLEC FLT1 RAB31 HNRNPA3 TREM1 EIF1 ATP2A2 | 4.13e-05 | 724 | 199 | 17 | M41700 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | DHRS3 CLSTN2 SCN7A COL14A1 PLEC SORBS2 RAB31 ANXA1 WWP1 APOA1 | 4.15e-05 | 268 | 199 | 10 | M45796 |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | ACAT1 CENPF ACLY HNRNPM NASP PFKP CMAS TUFM DDX41 HSPA4 HSPA9 HNRNPA3 RFC4 NUP155 AASS ENO2 | 5.63e-05 | 669 | 199 | 16 | M18635 |
| Coexpression | DESCARTES_ORGANOGENESIS_MYOCYTES | 5.99e-05 | 129 | 199 | 7 | MM3644 | |
| Coexpression | GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN | 6.28e-05 | 176 | 199 | 8 | M6757 | |
| Coexpression | MODY_HIPPOCAMPUS_POSTNATAL | 6.69e-05 | 56 | 199 | 5 | M10332 | |
| Coexpression | MODY_HIPPOCAMPUS_POSTNATAL | 6.69e-05 | 56 | 199 | 5 | MM648 | |
| Coexpression | KIM_ALL_DISORDERS_CALB1_CORR_UP | ATP6V1B2 PFKP TTC3 KIF3B PKM SYT1 DYNC1H1 KALRN HNRNPA3 KHDRBS3 USO1 SNCB ATP2A2 ENO2 | 8.14e-05 | 547 | 199 | 14 | M2110 |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 9.59e-05 | 187 | 199 | 8 | M6807 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | TPM2 KNTC1 CENPF MYO9B BFSP1 BLM PYGL ALDH1B1 FAT3 APOA1 RFC4 KHDRBS3 RAB11FIP4 DEPDC1B | 1.19e-04 | 567 | 199 | 14 | M45692 |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_DN | 1.28e-04 | 307 | 199 | 10 | M19745 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | KNTC1 CENPF TNFSF9 NASP CPSF2 HSPA4 HSPA9 RABGGTB NAA15 ANXA1 RFC4 FXR1 NUP155 SUPT16H ENO2 | 1.29e-04 | 644 | 199 | 15 | M10501 |
| Coexpression | GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_DN | 1.38e-04 | 197 | 199 | 8 | M8561 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP | 1.47e-04 | 199 | 199 | 8 | M7021 | |
| Coexpression | GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP | 1.47e-04 | 199 | 199 | 8 | M8354 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP | 1.47e-04 | 199 | 199 | 8 | M8401 | |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_UP | 1.47e-04 | 199 | 199 | 8 | M4945 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_DN | 1.47e-04 | 199 | 199 | 8 | M3919 | |
| Coexpression | GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN | 1.53e-04 | 200 | 199 | 8 | M4531 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_UP | 1.53e-04 | 200 | 199 | 8 | M3974 | |
| Coexpression | GSE339_CD4POS_VS_CD8POS_DC_UP | 1.53e-04 | 200 | 199 | 8 | M5108 | |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_DC_UP | 1.53e-04 | 200 | 199 | 8 | M5195 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN | 1.53e-04 | 200 | 199 | 8 | M5225 | |
| Coexpression | GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP | 1.53e-04 | 200 | 199 | 8 | M9083 | |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_DN | 1.87e-04 | 262 | 199 | 9 | M2584 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.99e-04 | 208 | 199 | 8 | M39233 | |
| Coexpression | TRAVAGLINI_LUNG_CLASSICAL_MONOCYTE_CELL | 2.34e-04 | 270 | 199 | 9 | M41699 | |
| Coexpression | TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP | 2.61e-04 | 274 | 199 | 9 | M2348 | |
| Coexpression | PILON_KLF1_TARGETS_UP | KNTC1 ABCA1 KIF3B COL14A1 C5 CPSF2 HSPA9 FLT1 BMP2K APOA1 SUPT16H NT5C2 AKR1B15 | 2.70e-04 | 541 | 199 | 13 | MM1061 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 2.75e-04 | 276 | 199 | 9 | M3063 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN | 2.77e-04 | 165 | 199 | 7 | M353 | |
| Coexpression | TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP | 2.83e-04 | 277 | 199 | 9 | MM917 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | SETX CENPF NASP KLHL41 ZNF518A RBM25 FMN1 HSPA4 DOCK1 WWP1 HNRNPA3 FCHO2 FXR1 AKAP9 SUPT16H PLEKHO1 | 6.93e-06 | 469 | 194 | 16 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 ACLY TTC3 PKM DYNC1H1 MIA3 NBEA SLC8A1 AKAP9 SCG3 ATP2A2 ATP2A3 | 8.85e-11 | 195 | 199 | 12 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 ACLY TTC3 PKM DYNC1H1 MIA3 NBEA SLC8A1 AKAP9 SCG3 ATP2A2 ATP2A3 | 8.85e-11 | 195 | 199 | 12 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | CFH HNRNPM RPS12 KLHL41 NEB CHRNA1 RBM25 SCN7A OGN FXR1 AKAP9 | 1.80e-09 | 200 | 199 | 11 | 7c261e39ac30b318511373ab7302aa53b8b81b9c |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.48e-08 | 200 | 199 | 10 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.48e-08 | 200 | 199 | 10 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | EPHB4 SETX PECAM1 FLT1 LAMA4 TEK HMCN1 KIAA1217 PRKCH PLEKHO1 | 2.48e-08 | 200 | 199 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-08 | 200 | 199 | 10 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.48e-08 | 200 | 199 | 10 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-07 | 189 | 199 | 9 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-07 | 189 | 199 | 9 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-07 | 189 | 199 | 9 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-07 | 189 | 199 | 9 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-07 | 190 | 199 | 9 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-07 | 192 | 199 | 9 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-07 | 192 | 199 | 9 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-07 | 192 | 199 | 9 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.27e-07 | 193 | 199 | 9 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-07 | 194 | 199 | 9 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 2.37e-07 | 194 | 199 | 9 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 2.48e-07 | 195 | 199 | 9 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.57e-07 | 59 | 199 | 6 | 74590437b1d9a2a8fe56d79b2e66803528b81298 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 2.59e-07 | 196 | 199 | 9 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.70e-07 | 197 | 199 | 9 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.70e-07 | 197 | 199 | 9 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 2.82e-07 | 198 | 199 | 9 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.94e-07 | 199 | 199 | 9 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-07 | 200 | 199 | 9 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-07 | 200 | 199 | 9 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 3.07e-07 | 200 | 199 | 9 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.07e-07 | 200 | 199 | 9 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 160 | 199 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 160 | 199 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-06 | 172 | 199 | 8 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-06 | 175 | 199 | 8 | c9dc6aa652ac887470806a950311657c423d9495 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 176 | 199 | 8 | eb63eb2c301e785196ccadac74a2940b2c524c62 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-06 | 179 | 199 | 8 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 184 | 199 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 184 | 199 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.83e-06 | 184 | 199 | 8 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 184 | 199 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 1.98e-06 | 186 | 199 | 8 | a16ecf70271894a842925f232009e2623d16947e | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-06 | 186 | 199 | 8 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.15e-06 | 188 | 199 | 8 | 5eb107122064f0a99dfd445cc87d3766f7257216 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 188 | 199 | 8 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.23e-06 | 189 | 199 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-06 | 189 | 199 | 8 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.32e-06 | 190 | 199 | 8 | e1b721bb74561fe51c53328a0394c9954e489049 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-06 | 190 | 199 | 8 | 92fdfed12061ee9f6c7171cf8a7f3344921f2d40 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-06 | 191 | 199 | 8 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.41e-06 | 191 | 199 | 8 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-06 | 191 | 199 | 8 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.41e-06 | 191 | 199 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.41e-06 | 191 | 199 | 8 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-06 | 191 | 199 | 8 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.51e-06 | 192 | 199 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 192 | 199 | 8 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|(1)_Control_(PBS) / Stress and Cell class | 2.51e-06 | 192 | 199 | 8 | e16e49b302019474232ef4cc0ff217d33afe34cf | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.61e-06 | 193 | 199 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 2.61e-06 | 193 | 199 | 8 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 2.71e-06 | 194 | 199 | 8 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | E12.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.71e-06 | 194 | 199 | 8 | 4b335e4da58de1cd94194dc4208ce83854e5e50a | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.82e-06 | 195 | 199 | 8 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-06 | 195 | 199 | 8 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-06 | 195 | 199 | 8 | 42bfdff88da1d07828c0ad65d412fb1752f0cee4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-06 | 195 | 199 | 8 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 2.82e-06 | 195 | 199 | 8 | 6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.82e-06 | 195 | 199 | 8 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 195 | 199 | 8 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.92e-06 | 196 | 199 | 8 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 2.92e-06 | 196 | 199 | 8 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.92e-06 | 196 | 199 | 8 | 89ff93cbfbe39fbdf2498e8fdc5d61a0ecb26fc9 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.92e-06 | 196 | 199 | 8 | 09574bfeb1d3da53b5471cfb0602946d328b3b5c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.92e-06 | 196 | 199 | 8 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 3.04e-06 | 197 | 199 | 8 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 3.04e-06 | 197 | 199 | 8 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 3.04e-06 | 197 | 199 | 8 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.04e-06 | 197 | 199 | 8 | 6f41c8f815851968849428ec92c16745bd01a3fb | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.04e-06 | 197 | 199 | 8 | 304044ace926943b8eb588f686ecbe5d1689a809 | |
| ToppCell | COVID-19-Heart-Mito_CM|Heart / Disease (COVID-19 only), tissue and cell type | 3.15e-06 | 198 | 199 | 8 | b6cd439863d17209b86dc50ae51282dc1725955d | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.15e-06 | 198 | 199 | 8 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.15e-06 | 198 | 199 | 8 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 3.15e-06 | 198 | 199 | 8 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | Parenchyma_COVID-19|World / Sample group, Lineage and Cell type | 3.15e-06 | 198 | 199 | 8 | 45ab554e6d0399b3182f089a25b2adf96de1144b | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.15e-06 | 198 | 199 | 8 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.27e-06 | 199 | 199 | 8 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.27e-06 | 199 | 199 | 8 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | healthy_donor-Myeloid-Monocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.27e-06 | 199 | 199 | 8 | bd66a8d1a7cc92313328acc7c7ae0442faff951e | |
| ToppCell | ASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.27e-06 | 199 | 199 | 8 | 93e85e3731a9ece9aee3eb82c5dfdad331ee62d6 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.27e-06 | 199 | 199 | 8 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.27e-06 | 199 | 199 | 8 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-SPP1+_Mac|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.27e-06 | 199 | 199 | 8 | c7fc2ac1601346aac71e7620a8a440fde8d92dbd | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 3.27e-06 | 199 | 199 | 8 | f89d67e3d8cd48ef5c30a5ad71764f4ebbc8bcb3 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.27e-06 | 199 | 199 | 8 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | healthy_donor-Myeloid|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.27e-06 | 199 | 199 | 8 | d41994e08f7c3f5bd865b689db8f032efbe88d24 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.27e-06 | 199 | 199 | 8 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 3.27e-06 | 199 | 199 | 8 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.40e-06 | 200 | 199 | 8 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.40e-06 | 200 | 199 | 8 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.40e-06 | 200 | 199 | 8 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.40e-06 | 200 | 199 | 8 | 137f8f9d255c66336d4f8b44b2e3f3de721f2bf0 | |
| Computational | Genes in the cancer module 80. | 3.71e-05 | 32 | 130 | 5 | MODULE_80 | |
| Computational | Genes in the cancer module 51. | 6.68e-05 | 36 | 130 | 5 | MODULE_51 | |
| Drug | acetate | ACAT1 ACLY PECAM1 PFKP TUFM NIT2 PKM DLD ALDH1B1 ALDH1A3 ALDH3A2 DYNC1H1 ADSS1 FCHO2 DNAH1 MTHFD1 PRKCH ATP2A1 ATP2A2 ATP2A3 ATP2B2 SLC33A1 | 1.17e-08 | 599 | 196 | 22 | CID000000175 |
| Drug | acetyl phosphate | 1.76e-07 | 98 | 196 | 9 | CID000000186 | |
| Drug | Cocaine | EPHB4 CFH PECAM1 ETF1 NCF2 BTBD9 NEB HCN2 PLXNB2 NIT2 PKM SYT1 PLEC DDX41 HSPA9 FRAS1 RAB31 NAA15 CCDC73 BMP2K KALRN ATG2B RTN4IP1 SYT2 DHX30 CD4 USO1 SNCB ENO2 MUSK | 9.75e-07 | 1314 | 196 | 30 | ctd:D003042 |
| Drug | ATP-EDC | 1.07e-06 | 10 | 196 | 4 | CID000195647 | |
| Drug | 1sqc | 1.07e-06 | 10 | 196 | 4 | CID000444279 | |
| Drug | oxalate | 1.18e-06 | 158 | 196 | 10 | CID000000971 | |
| Drug | 2,5-dimethylquinone | 1.68e-06 | 11 | 196 | 4 | CID000008718 | |
| Drug | 1vyq | 2.50e-06 | 12 | 196 | 4 | CID004369390 | |
| Drug | p-hydroxyhippuric acid | 4.98e-06 | 14 | 196 | 4 | CID000151012 | |
| Drug | Thapsigargin | DHX36 DHRS3 CENPF TNFSF9 ACLY PFKP NDUFA9 LARP4 BLM RBM25 PKM DLD C5 ALDH1A3 HSPA9 BMP2K NDUFAF2 HNRNPA3 NBEA SLC8A1 NUP155 USO1 MTHFD1 PRKCH EIF1 ATP2A1 ATP2A2 ATP2A3 DEPDC1B | 5.21e-06 | 1353 | 196 | 29 | ctd:D019284 |
| Drug | magnesium | TPM2 EPHB4 ATP6V1B2 PFKP CMAS TUFM PKM DLD ADAM17 PLEC ALDH1B1 ALDH3A2 DYNC1H1 ADSS1 RAB31 TOM1L1 LAMA4 RFC4 DNAH1 ARHGDIB MTHFD1 NT5C2 PRKCH ATP2A1 ATP2A2 ATP2A3 ENO2 ATP2B2 | 1.00e-05 | 1325 | 196 | 28 | CID000000888 |
| Drug | AC1L88YH | 1.16e-05 | 17 | 196 | 4 | CID000374551 | |
| Drug | PPCM | 1.16e-05 | 59 | 196 | 6 | CID000001292 | |
| Drug | hydroxyl radicals | ATP6V1B2 ACAT1 EIF1B CLSTN2 TUFM KIF3B PKM SYT1 DLD ALDH1B1 ALDH1A3 ALDH3A2 HSPA4 DMGDH ANXA1 PIGS TGM1 CD4 MTHFD1 AASS NT5C2 PRKCH HAL ATP2A1 ATP2A2 ATP2A3 ENO2 ATP2B2 | 1.25e-05 | 1341 | 196 | 28 | CID000000961 |
| Drug | Pe v | 1.30e-05 | 164 | 196 | 9 | CID005326793 | |
| Drug | imisopasem manganese | 1.48e-05 | 18 | 196 | 4 | ctd:C121876 | |
| Drug | neotrehalose | 1.74e-05 | 214 | 196 | 10 | CID000001143 | |
| Drug | nitrous oxide | 1.96e-05 | 96 | 196 | 7 | CID000000948 | |
| Drug | pyruvic acid | ACAT1 ACLY PFKP PKM DLD PYGL PLEC ALDH1B1 ALDH3A2 HSPA4 AASS HAL ENO2 HAO2 | 1.99e-05 | 424 | 196 | 14 | CID000001060 |
| Drug | quindine | CFH PRPF31 PECAM1 HCN2 CHRNA1 SCN7A ATP2A1 ATP2A2 ATP2A3 SLC33A1 | 2.13e-05 | 219 | 196 | 10 | CID000001065 |
| Drug | 3-butynoate | 2.14e-05 | 7 | 196 | 3 | CID000137547 | |
| Drug | 3-butynal | 2.14e-05 | 7 | 196 | 3 | CID000142966 | |
| Drug | TMB-8 | 2.28e-05 | 176 | 196 | 9 | CID000005494 | |
| Drug | vinylidene chloride | KNTC1 ABCA1 DHRS3 ACAT1 CENPF PFKP ACSF3 DLD PYGL PLEC ALDH1B1 DMGDH FLT1 RAB31 ANXA1 WWP1 NBEA RFC4 TEK SNX29 SLC8A1 MTHFD1 AASS RAB11FIP4 KDM1B PLEKHO1 ENO2 ATP2B2 HAO2 | 2.64e-05 | 1475 | 196 | 29 | ctd:C029297 |
| Drug | strontium | 2.65e-05 | 68 | 196 | 6 | CID000104798 | |
| Drug | C12E8 | 2.95e-05 | 42 | 196 | 5 | CID000123921 | |
| Drug | C04554 | 3.41e-05 | 8 | 196 | 3 | CID000440384 | |
| Drug | AC1NUZ0S | 3.41e-05 | 8 | 196 | 3 | CID005496754 | |
| Drug | succinate | ACAT1 PKM DLD ADSS1 NDUFAF2 AASS HAL ATP2A1 ATP2A2 ATP2A3 ENO2 ATP2B2 | 4.03e-05 | 339 | 196 | 12 | CID000001110 |
| Drug | AC1L25Y6 | 4.15e-05 | 23 | 196 | 4 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 4.15e-05 | 23 | 196 | 4 | CID000165791 | |
| Drug | bromfenacoum | ACLY TUFM ADD1 SYT1 ALDH3A2 HSPA9 NAA15 SYT2 CRKL SMG8 FXR1 AKAP9 MTHFD1 SNCB EIF1 ATP2A2 ATP2B2 | 4.51e-05 | 644 | 196 | 17 | ctd:C013418 |
| Drug | CPD 30 | 5.08e-05 | 9 | 196 | 3 | CID000440850 | |
| Drug | R 8231 | 5.08e-05 | 9 | 196 | 3 | CID003084926 | |
| Drug | 4-acetamidobutyrate | 5.08e-05 | 9 | 196 | 3 | CID000018189 | |
| Drug | Prednisolone [50-24-8]; Down 200; 11uM; HL60; HT_HG-U133A | 5.29e-05 | 196 | 196 | 9 | 2393_DN | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; PC3; HT_HG-U133A | 5.72e-05 | 198 | 196 | 9 | 3810_UP | |
| Drug | EUK-8 | 5.85e-05 | 25 | 196 | 4 | CID000171249 | |
| Drug | cyhexatin | 5.85e-05 | 25 | 196 | 4 | CID005364545 | |
| Drug | menadione | ETF1 MIA2 FMN1 DLD HSPA4 NDUFAF2 CRKL ATP2A1 ATP2A2 ATP2A3 ATP2B2 | 6.19e-05 | 300 | 196 | 11 | CID000004055 |
| Drug | dodecyl ether | 6.86e-05 | 26 | 196 | 4 | CID000020667 | |
| Drug | tricyclohexyltin chloride | 7.21e-05 | 10 | 196 | 3 | CID000076539 | |
| Drug | Me-DTC | 7.21e-05 | 10 | 196 | 3 | CID000012704 | |
| Drug | C13932 | 7.76e-05 | 206 | 196 | 9 | CID000168297 | |
| Drug | troglitazone | CFH KNTC1 ABCA1 DHRS3 ACAT1 CENPF TNFSF9 ACLY NASP ZSWIM2 CLSTN2 ITGAV BLM PYGL PLEC HSPA4 HSPA9 DMGDH FLT1 MXRA5 LAMA4 APOA1 RFC4 TEK AKR1B15 HAL | 7.80e-05 | 1329 | 196 | 26 | ctd:C057693 |
| Drug | benzoquinone | 8.67e-05 | 209 | 196 | 9 | CID000004650 | |
| Drug | persulfate | 9.85e-05 | 11 | 196 | 3 | CID000024413 | |
| Drug | ynoate | 9.85e-05 | 11 | 196 | 3 | CID000010110 | |
| Drug | octaethylene glycol | 1.07e-04 | 29 | 196 | 4 | CID000078798 | |
| Drug | phosphocreatine disodium | 1.12e-04 | 126 | 196 | 7 | CID000000587 | |
| Drug | aldonates | 1.29e-04 | 90 | 196 | 6 | CID000000752 | |
| Drug | imidazole acetaldehyde | 1.31e-04 | 12 | 196 | 3 | CID000150841 | |
| Drug | AC1L1JAO | 1.31e-04 | 57 | 196 | 5 | CID000004955 | |
| Drug | AC1Q68Z5 | ACAT1 ACLY PFKP MSL3 PKM ACSF3 SYT1 DLD ALDH1B1 ALDH3A2 NAA15 SLC33A1 | 1.38e-04 | 386 | 196 | 12 | CID000000181 |
| Drug | 2,5-anhydro-D-mannitol | 1.40e-04 | 31 | 196 | 4 | CID000001494 | |
| Drug | ammonia | CLSTN2 PFKP NIT2 PKM SYT1 DLD PLEC ADSS1 TGM1 MTHFD1 CNTN3 HAL ATP2A1 ENO2 | 1.41e-04 | 509 | 196 | 14 | CID000000222 |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.42e-04 | 175 | 196 | 8 | 1006_UP | |
| Drug | testosterone enanthate | EPHB4 CFH TTC3 ITGAV RBM25 SYCP1 COL14A1 ALDH1B1 ALDH1A3 HSPA4 MXRA5 NAA15 BMP2K LAMA4 FXR1 | 1.45e-04 | 575 | 196 | 15 | ctd:C004648 |
| Drug | AC1MMLID | 1.45e-04 | 92 | 196 | 6 | CID000013245 | |
| Drug | CC270 | 1.54e-04 | 59 | 196 | 5 | CID006918852 | |
| Drug | ptaquiloside | 1.57e-04 | 133 | 196 | 7 | ctd:C043680 | |
| Drug | AC1MIVRO | 1.59e-04 | 32 | 196 | 4 | CID003080809 | |
| Drug | methylmalonate semialdehyde | 1.59e-04 | 32 | 196 | 4 | CID000000296 | |
| Disease | Brody myopathy (implicated_via_orthology) | 2.71e-07 | 3 | 192 | 3 | DOID:0050692 (implicated_via_orthology) | |
| Disease | Nemaline Myopathy, Childhood Onset | 9.31e-06 | 7 | 192 | 3 | C0546125 | |
| Disease | Intellectual Disability | KDM5C BRWD3 MSL3 SYT1 ALDH3A2 DYNC1H1 NAA15 NBEA CTCF AASS SUPT16H NT5C2 | 4.00e-05 | 447 | 192 | 12 | C3714756 |
| Disease | right ventricular ejection fraction measurement | 4.17e-05 | 30 | 192 | 4 | EFO_0021816 | |
| Disease | corneal neovascularization (implicated_via_orthology) | 4.21e-05 | 2 | 192 | 2 | DOID:11382 (implicated_via_orthology) | |
| Disease | lactoylglutathione lyase measurement | 4.21e-05 | 2 | 192 | 2 | EFO_0802684 | |
| Disease | Apolipoprotein A-I deficiency | 4.21e-05 | 2 | 192 | 2 | C0342898 | |
| Disease | hypolipoproteinemia (is_implicated_in) | 4.21e-05 | 2 | 192 | 2 | DOID:1387 (is_implicated_in) | |
| Disease | Familial hypoalphalipoproteinemia | 4.21e-05 | 2 | 192 | 2 | cv:C1704429 | |
| Disease | Hypoalphalipoproteinemia, Familial | 4.21e-05 | 2 | 192 | 2 | C1704429 | |
| Disease | C5a anaphylatoxin measurement | 1.26e-04 | 3 | 192 | 2 | EFO_0020208 | |
| Disease | hypertension (biomarker_via_orthology) | 1.28e-04 | 227 | 192 | 8 | DOID:10763 (biomarker_via_orthology) | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 1.43e-04 | 16 | 192 | 3 | DOID:3635 (implicated_via_orthology) | |
| Disease | psoriasis (is_marker_for) | 1.92e-04 | 44 | 192 | 4 | DOID:8893 (is_marker_for) | |
| Disease | congenital myasthenic syndrome 7 (implicated_via_orthology) | 2.51e-04 | 4 | 192 | 2 | DOID:0110659 (implicated_via_orthology) | |
| Disease | Alzheimer's disease (is_marker_for) | 2.96e-04 | 257 | 192 | 8 | DOID:10652 (is_marker_for) | |
| Disease | disease of metabolism (implicated_via_orthology) | 3.31e-04 | 21 | 192 | 3 | DOID:0014667 (implicated_via_orthology) | |
| Disease | splicing factor 3B subunit 4 measurement | 4.16e-04 | 5 | 192 | 2 | EFO_0803100 | |
| Disease | neuromuscular junction disease (implicated_via_orthology) | 4.16e-04 | 5 | 192 | 2 | DOID:439 (implicated_via_orthology) | |
| Disease | Immunologic Deficiency Syndromes | 4.36e-04 | 23 | 192 | 3 | C0021051 | |
| Disease | platelet component distribution width | EPHB4 GIPC2 MYO9B PECAM1 SLFN14 MIA2 PLEC BMP2K KALRN PACSIN1 CRKL AGBL2 MUSK SPIN3 | 4.54e-04 | 755 | 192 | 14 | EFO_0007984 |
| Disease | Myasthenic Syndromes, Congenital | 4.96e-04 | 24 | 192 | 3 | C0751882 | |
| Disease | HIV Infections | 5.79e-04 | 103 | 192 | 5 | C0019693 | |
| Disease | HIV Coinfection | 5.79e-04 | 103 | 192 | 5 | C4505456 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 6.21e-04 | 6 | 192 | 2 | C1854678 | |
| Disease | triggering receptor expressed on myeloid cells 1 measurement | 6.21e-04 | 6 | 192 | 2 | EFO_0802161 | |
| Disease | angiopoietin-1 receptor, soluble measurement | 6.21e-04 | 6 | 192 | 2 | EFO_0008023 | |
| Disease | myeloperoxidase measurement | 6.32e-04 | 26 | 192 | 3 | EFO_0005243 | |
| Disease | transitional cell carcinoma (biomarker_via_orthology) | 8.66e-04 | 7 | 192 | 2 | DOID:2671 (biomarker_via_orthology) | |
| Disease | 1,5 anhydroglucitol measurement | 8.75e-04 | 29 | 192 | 3 | EFO_0008009 | |
| Disease | phosphatidylethanolamine measurement | 9.75e-04 | 173 | 192 | 6 | EFO_0010228 | |
| Disease | platelet measurement | 1.12e-03 | 315 | 192 | 8 | EFO_0005036 | |
| Disease | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 1.15e-03 | 8 | 192 | 2 | C0796250 | |
| Disease | nemaline myopathy (implicated_via_orthology) | 1.15e-03 | 8 | 192 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | programmed cell death 1 ligand 2 measurement | 1.15e-03 | 8 | 192 | 2 | EFO_0008268 | |
| Disease | Myopathies, Nemaline | 1.15e-03 | 8 | 192 | 2 | C0206157 | |
| Disease | Nemaline myopathy | 1.15e-03 | 8 | 192 | 2 | cv:C0206157 | |
| Disease | fatty liver disease (biomarker_via_orthology) | 1.28e-03 | 33 | 192 | 3 | DOID:9452 (biomarker_via_orthology) | |
| Disease | albumin:globulin ratio measurement | 1.33e-03 | 73 | 192 | 4 | EFO_0005128 | |
| Disease | angina pectoris | 1.38e-03 | 125 | 192 | 5 | EFO_0003913 | |
| Disease | adult respiratory distress syndrome (implicated_via_orthology) | 1.47e-03 | 9 | 192 | 2 | DOID:11394 (implicated_via_orthology) | |
| Disease | heart disease (implicated_via_orthology) | 1.93e-03 | 38 | 192 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 2.02e-03 | 346 | 192 | 8 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | post-traumatic stress disorder symptom measurement | 2.05e-03 | 82 | 192 | 4 | EFO_0008535 | |
| Disease | Cardiomegaly | 2.05e-03 | 82 | 192 | 4 | C0018800 | |
| Disease | Cardiac Hypertrophy | 2.05e-03 | 82 | 192 | 4 | C1383860 | |
| Disease | thyroxine measurement | 2.14e-03 | 83 | 192 | 4 | EFO_0005130 | |
| Disease | Diabetic Cardiomyopathies | 2.23e-03 | 11 | 192 | 2 | C0853897 | |
| Disease | uveitis (implicated_via_orthology) | 2.23e-03 | 11 | 192 | 2 | DOID:13141 (implicated_via_orthology) | |
| Disease | bipolar I disorder | 2.34e-03 | 141 | 192 | 5 | EFO_0009963 | |
| Disease | visceral adipose tissue measurement, body mass index | 2.54e-03 | 87 | 192 | 4 | EFO_0004340, EFO_0004765 | |
| Disease | Congenital myopathy (disorder) | 2.66e-03 | 12 | 192 | 2 | C0270960 | |
| Disease | beta-endorphin measurement | 2.66e-03 | 12 | 192 | 2 | EFO_0008034 | |
| Disease | FEV/FEC ratio | EFCAB5 GIPC2 WWC3 NASP NEB ITGAV KIF3B HSPA4 FLT1 FRAS1 NAA15 PCDHGA5 DENND3 SLC8A1 HMCN1 CTCF ATP2A3 | 2.87e-03 | 1228 | 192 | 17 | EFO_0004713 |
| Disease | mean platelet volume | MYO9B PECAM1 NFASC PFKP SLFN14 PLEC ALDH3A2 KALRN PCDHGA7 PCDHGA5 FCHO2 CRKL MUSK MYBPC3 SPIN3 | 2.88e-03 | 1020 | 192 | 15 | EFO_0004584 |
| Disease | fatty acid measurement, fetal genotype effect measurement, breast milk measurement | 3.13e-03 | 13 | 192 | 2 | EFO_0005110, EFO_0007959, EFO_0009092 | |
| Disease | extracellular matrix protein 1 measurement | 3.13e-03 | 13 | 192 | 2 | EFO_0008126 | |
| Disease | Leigh Disease | 3.56e-03 | 47 | 192 | 3 | C0023264 | |
| Disease | severe acute respiratory syndrome (is_marker_for) | 3.56e-03 | 47 | 192 | 3 | DOID:2945 (is_marker_for) | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 3.64e-03 | 14 | 192 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | fatty acid measurement, breast milk measurement, parental genotype effect measurement | 3.64e-03 | 14 | 192 | 2 | EFO_0005110, EFO_0005939, EFO_0009092 | |
| Disease | diacylglycerol 38:4 measurement | 3.64e-03 | 14 | 192 | 2 | EFO_0020066 | |
| Disease | pimelic acid measurement, 3-methyladipic acid measurement | 3.64e-03 | 14 | 192 | 2 | EFO_0010449, EFO_0010524 | |
| Disease | frontal fibrosing alopecia | 3.78e-03 | 48 | 192 | 3 | EFO_0009855 | |
| Disease | triglyceride measurement, alcohol drinking | 4.04e-03 | 99 | 192 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | Duchenne muscular dystrophy, disease progression measurement | 4.25e-03 | 50 | 192 | 3 | EFO_0008336, MONDO_0010679 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 4.34e-03 | 101 | 192 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | pulse pressure measurement | EPHB4 CFH PECAM1 LARP4 PLXNB2 RBM25 SYT1 MXRA5 FAT3 PCDHA4 NBEA PCDHA1 KHDRBS3 KIAA1217 NT5C2 AGBL2 MUSK MYBPC3 | 4.44e-03 | 1392 | 192 | 18 | EFO_0005763 |
| Disease | total lipids in LDL measurement | 4.74e-03 | 52 | 192 | 3 | EFO_0022308 | |
| Disease | atherosclerosis (is_implicated_in) | 4.76e-03 | 16 | 192 | 2 | DOID:1936 (is_implicated_in) | |
| Disease | obesity | 5.09e-03 | 241 | 192 | 6 | EFO_0001073 | |
| Disease | Schizophrenia | ABCA1 MYO9B NFASC BTBD9 CMYA5 HSPA9 HNRNPA3 CTCF MTHFD1 TREM1 SNCB ATP2A2 ENO2 | 5.36e-03 | 883 | 192 | 13 | C0036341 |
| Disease | Antibody Deficiency Syndrome | 5.37e-03 | 17 | 192 | 2 | C0003257 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 5.37e-03 | 17 | 192 | 2 | cv:C0270914 | |
| Disease | HOMA-B | 5.55e-03 | 55 | 192 | 3 | EFO_0004469 | |
| Disease | creatinine measurement | CFH GIPC2 CAND2 CENPF NASP NEB PLXNB2 BRWD3 SYT1 PLEC ALDH3A2 DMGDH SLC8A1 MUSK | 5.78e-03 | 995 | 192 | 14 | EFO_0004518 |
| Disease | cortical thickness, neuroimaging measurement | 5.87e-03 | 110 | 192 | 4 | EFO_0004346, EFO_0004840 | |
| Disease | mean corpuscular hemoglobin concentration | KNTC1 GIPC2 MYO9B BTBD9 NEB ACSBG1 BMP2K KALRN PCDHGA5 FCHO2 CTCF KIAA1217 NT5C2 ENO2 MUSK | 5.98e-03 | 1105 | 192 | 15 | EFO_0004528 |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 6.02e-03 | 18 | 192 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | essential hypertension (is_implicated_in) | 6.02e-03 | 18 | 192 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | Age-related macular degeneration | 6.02e-03 | 18 | 192 | 2 | cv:C0242383 | |
| Disease | triacylglycerol 56:3 measurement | 6.02e-03 | 18 | 192 | 2 | EFO_0010430 | |
| Disease | serum IgG measurement | 6.02e-03 | 18 | 192 | 2 | EFO_0004565 | |
| Disease | Hemangiosarcoma | 6.02e-03 | 18 | 192 | 2 | C0018923 | |
| Disease | total lipids in large LDL | 6.13e-03 | 57 | 192 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 6.13e-03 | 57 | 192 | 3 | EFO_0021901 | |
| Disease | Liver carcinoma | 6.20e-03 | 507 | 192 | 9 | C2239176 | |
| Disease | cognitive behavioural therapy | 6.44e-03 | 58 | 192 | 3 | EFO_0007820 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEKYELKEGQTLDVK | 26 | Q9NP99 | |
| REKTEGVVSIKEDKY | 801 | Q5TYW2 | |
| VVKEETQGITDTYKL | 286 | O00400 | |
| EGDLDKAIEVYKKAV | 181 | Q96RK4 | |
| IEGETKESNYAKLIE | 3486 | Q99996 | |
| REKAEGVVSIKEDKY | 801 | Q5CZ79 | |
| KLRYTEEGKDVDVSV | 211 | P49711 | |
| KLILEYVKASEAGEV | 236 | Q7L5N1 | |
| YNIQKKEIVVKGDEV | 11 | Q6P1J9 | |
| KIVKDGEEEIVYAVD | 161 | Q9P2I0 | |
| EKTVENLEKYVVKDG | 216 | P49902 | |
| IIKEGIESQASYKIV | 36 | Q99965 | |
| EDGLKAYTEVKTVTI | 496 | P30837 | |
| EYLTANILEKVGKEV | 56 | A0A3B3IU63 | |
| ELIKEVQKYGEEQVK | 96 | Q0JRZ9 | |
| SVAVIIKGIVYEKEA | 651 | O95477 | |
| IDKAKEVGATIESYI | 616 | Q9UDR5 | |
| EYTEVKTVTIKLGDK | 496 | P47895 | |
| VLKEGDEEIKSDIYT | 376 | A8MVX0 | |
| EKLIGYTKTVTEVLA | 291 | P51684 | |
| TAKGDIEISLYTVEK | 751 | Q6RI45 | |
| IKETVKEFYGENIKE | 261 | P51648 | |
| VYSVSKQGVVILDDK | 221 | Q8WUY9 | |
| VKGIEKEVNVYKSED | 111 | Q8TF65 | |
| IIKTGGYKVSALEVE | 476 | Q4G176 | |
| KDLATVYVDVLKDSG | 36 | P02647 | |
| VKEKTKEEYGHSEVV | 641 | P08603 | |
| TVQGIADDYDKKKLV | 46 | O60739 | |
| SVEVEGYGSKKIDAE | 96 | Q7L2E3 | |
| KAVVTEGKIYDSILQ | 166 | Q9H4D0 | |
| KGKIYVIDAERKTVE | 1146 | A2RUS2 | |
| KDGVNVVEEEIKKYT | 211 | Q9NSY1 | |
| LVKEAIDKAGYTEKI | 226 | P09104 | |
| KGVYEKVGEATETAL | 431 | O14983 | |
| KGVYEKVGEATETAL | 431 | Q93084 | |
| EAVVKIKETYGDTEA | 41 | Q01814 | |
| EGVAKAYSVVKEGIT | 1991 | Q96BY7 | |
| NKKIIEYIGEEEATL | 776 | P49756 | |
| YLVTKVVAVDKDSGQ | 586 | Q9Y5G6 | |
| KDAKEYAESIGAIVV | 131 | Q13636 | |
| KVELVTGEEGEKVLY | 1046 | Q99666 | |
| KVELVTGEEGEKVLY | 1046 | O14715 | |
| EAYGKLEREKATEVE | 406 | Q86YS3 | |
| TKDTEEKVGLKYTEA | 706 | Q68DA7 | |
| YLVTKVVAVDKDSGQ | 586 | Q9Y5G8 | |
| QNIEDEEETKKVLGY | 286 | Q8IXS6 | |
| EEETKKVLGYDETIK | 291 | Q8IXS6 | |
| EVKSAIEGIKYIAET | 391 | P02708 | |
| REKTEGVVSIKEDKY | 801 | Q5SQ80 | |
| AILDETKGDYEKILV | 326 | P04083 | |
| TIVDVYTVEQLKGKA | 296 | Q8N635 | |
| SILTKLIVESYEGEK | 76 | P0C881 | |
| SILTKLIVESYEGEK | 76 | B2RC85 | |
| YDHVEEVTKEGVKKS | 3171 | Q86XX4 | |
| KKEDIYAVEIVGGAT | 331 | P34932 | |
| KDYLGKATVVASVVD | 196 | P19878 | |
| FAKEIDVSYVKIEEV | 606 | P54760 | |
| DDGVSKDAVTEKKYI | 806 | Q2M2H8 | |
| KKEISEGDEVEVYSR | 56 | P51114 | |
| VVVVCEKTEKNGEYS | 86 | Q8WX39 | |
| SLKDLVKEKVGEVTY | 86 | P52272 | |
| KVLKESDDGVVVYVA | 801 | Q8IY21 | |
| ELSAEVVEEVEKYKA | 376 | Q69YN2 | |
| TVQGIADDYDKKKLV | 46 | P41567 | |
| YEKIKSQLEGLEESV | 1231 | O15031 | |
| EISGKDYVQEVTKAG | 96 | Q9H2J4 | |
| EKIKELVVTQLGYDT | 286 | Q01813 | |
| KEKTTAEYQVLVEGV | 116 | P16284 | |
| ELVQTEKDYVKDLGI | 1936 | O60229 | |
| YDAKIVDVIVGKDEK | 31 | Q8N5Y2 | |
| VDDKIYVVAGKDLQT | 396 | O60662 | |
| GVVEKLLKTYETATE | 561 | Q6ZU52 | |
| YLDGKNIKEKETVII | 51 | P20774 | |
| KVVEVGSKIYVDDGL | 166 | P14618 | |
| KVILEKAGKYVDEEN | 121 | Q8N9T8 | |
| EDKTALIYSDGLKEV | 501 | P50748 | |
| KVEAQVYILSKEEGG | 351 | P49411 | |
| YDKTALALEVGDIVK | 251 | P46109 | |
| LDVIQEVEYVKEEAK | 406 | Q9UJV9 | |
| GLDKSEDKVIAVYDL | 231 | P38646 | |
| YVVDVSKGIVNAVKD | 241 | Q16795 | |
| KEAEGSSAEYKKEIE | 626 | P49321 | |
| KEKVAIIEELVVGYE | 336 | Q9BXJ9 | |
| TEEQVLDVKGYLSKV | 71 | O95140 | |
| YEGVVELSLTAAEKK | 926 | O75694 | |
| SVAGEKEIKYEVDVL | 1716 | Q96RW7 | |
| QEKYEKVLEDVGKTT | 206 | Q9BY11 | |
| EETKSYEIQVKAVDK | 311 | Q9Y5I3 | |
| VNKVVEYVKGLQKED | 116 | P53611 | |
| EESKSYEIIVEGIDK | 311 | Q9UN74 | |
| IGQYTVKKDKEETEG | 1316 | O94856 | |
| SKVAEVAGKEYAIEQ | 1146 | Q9P2D7 | |
| EFSGEIKKKYILEIE | 1301 | A4FU69 | |
| REKTEGVVSIKEDKY | 801 | Q5VUR7 | |
| KGVYEKVGEATETAL | 431 | P16615 | |
| EVIDSIIKEKTVVYG | 151 | P42357 | |
| EKIEEIYKAFIKESG | 511 | Q8NB78 | |
| VTEDKLEKYGAEVIS | 1266 | P54132 | |
| KNVEVTVSVYDEDGK | 446 | Q14185 | |
| VEKEGKVREEIAEYQ | 2686 | P49454 | |
| KETIVLKEGSEYRVK | 96 | P52566 | |
| VYGGKTEEVVLKEEQ | 661 | Q05707 | |
| EESEKVSVVKVYLQD | 451 | Q5SYB0 | |
| GKKVDYVQVDLEKTQ | 536 | Q2WGN9 | |
| DDVVYVIDGGKIKET | 561 | Q9H2U1 | |
| ALAYKTVEVVESIEK | 616 | Q12934 | |
| IKDVTKYKEGAVDAD | 206 | A8TX70 | |
| LLDIYKTGEAVAEKD | 1581 | P01031 | |
| LYEEAVGEKKKEEET | 3196 | Q8N3K9 | |
| LEVSVDSDQKKIYIG | 636 | P06756 | |
| GKYQLATEIKEKEIE | 106 | Q6ZRK6 | |
| EVYKLEVTNKEGDLK | 441 | Q8TDW7 | |
| EVQIEEVRQVGSYKK | 96 | Q12905 | |
| KASSIVYKKEGEQVE | 206 | P01730 | |
| GKDYESTEIVAEETK | 291 | P24588 | |
| EKKDEAVYQAIEEGI | 651 | Q96GR2 | |
| EIVGEKKGTVVYQLD | 216 | Q5U5Z8 | |
| VTGEKLYEIKILEET | 836 | Q5TB80 | |
| YVGKNTSEVKEDVVL | 441 | O43303 | |
| EEQLKEEGIEYKVGK | 406 | P09622 | |
| DVVKGVYKEKDNEEL | 506 | Q71RC2 | |
| DSIKLYEKLEEETGQ | 111 | Q9UI17 | |
| AYENVKEVDGLDVSK | 526 | Q14204 | |
| KGEGKDEEKYIDVVI | 36 | O75525 | |
| IVEAKYSVKGLESDE | 376 | Q8NDH2 | |
| ETGISDITKKEKEYD | 596 | Q8NDH2 | |
| IGEEYGDVTFVVEKK | 31 | Q96Q07 | |
| VVKVKEYQVETIVDT | 76 | O75155 | |
| LIVEKGIDSEVYKTA | 306 | Q9UL51 | |
| LSEEVELYGETKAKV | 341 | P11586 | |
| IKEDYIIEVKATTDG | 966 | Q9P232 | |
| EEVYQTAKAVREKVG | 101 | O75911 | |
| KYDVISVQGTEKLIE | 161 | Q6ZNG9 | |
| KVELVTGEEGEKVLY | 1031 | P0DJD0 | |
| IYAEIDGAKSELQVK | 561 | Q16363 | |
| TKGEEISVYVKLAGE | 61 | Q96PC5 | |
| VIKDDVASEVYKAVA | 456 | Q96S52 | |
| KTIEKIVEEGYTLSD | 1256 | Q6ZN16 | |
| AASKLYEVAIDGKEE | 451 | Q8ND04 | |
| DVIDYKSGSVEEQLK | 251 | Q8WWV3 | |
| VQVVVTVLDYDKIGK | 356 | P21579 | |
| VVTVLDYDKLGKNEA | 356 | Q8N9I0 | |
| VTEAAEKTKEGVLYV | 26 | Q16143 | |
| GLVKKSKDVVDYSEE | 211 | P21281 | |
| EGVITKAIYKSSEED | 621 | O60763 | |
| KISDEGIAYLVKVSE | 221 | P35249 | |
| GYVLIGVDDKSKEVV | 241 | P0C7P3 | |
| VSEVKEVYLDLVKKG | 136 | O75674 | |
| ILDVLGEVKVGVSYK | 366 | Q8N142 | |
| GYQKLDVKSIDDEDV | 336 | Q8TEQ0 | |
| DEKAVSAAEEVKTYK | 1556 | Q5JRA6 | |
| DQKEIISYDVKDAIG | 296 | Q8NFW8 | |
| LTEVVAAVKGKIEVY | 261 | Q9NYQ3 | |
| KAAIEYGTEEDVVKS | 2096 | Q8NFP9 | |
| GKKTLQVVVYEEEEE | 1596 | Q5T5P2 | |
| YVSEVVKKGAEGIEE | 1126 | Q7Z333 | |
| VEEILDGNDEKYKAV | 96 | Q12824 | |
| GTEEAIVYSDIDLKK | 236 | Q9NQR4 | |
| EDLIVKDGLTDVYNK | 176 | P24752 | |
| VEKAIEEKKYLAGAD | 221 | Q9Y5B9 | |
| VVLKGDQLYISEKEV | 46 | Q53GL0 | |
| VSYVEVVKKNTKGAE | 991 | O94875 | |
| VVTKDGVYVLDLAAK | 206 | P53396 | |
| GKVKEAVKVAIDAEY | 26 | C9JRZ8 | |
| VVVVDGKNESEYTVK | 96 | P78536 | |
| GELVTASKAIIEKEY | 536 | P35611 | |
| LLKGYSVDVDTEAKV | 756 | Q9BXU1 | |
| GTYIKDDTIFIKVIV | 546 | Q13114 | |
| EDGSYEVKSVLGKEV | 866 | Q14159 | |
| GKEKAASYDKVVDVD | 21 | O15066 | |
| ASYDKVVDVDVKLGQ | 26 | O15066 | |
| TDTYQKEIEDKKISE | 661 | Q15431 | |
| IDSLVGKQVEYAKDD | 206 | Q5JUX0 | |
| STEGKVGYELKDEIE | 311 | Q8WWY3 | |
| NIKTKVEEISKAGEY | 1186 | P53804 | |
| VEEISKAGEYVRVKL | 1191 | P53804 | |
| IVEAANKKEVDYEAG | 51 | Q8N183 | |
| VKDYGKESQAKDVIE | 111 | P25398 | |
| KKIFVGGIKEDTEEY | 126 | P51991 | |
| VKELGADYIDGTEKI | 141 | A6NFE2 | |
| ADYIDGTEKIDNIIK | 146 | A6NFE2 | |
| VLIKEEDAVIYKNGS | 146 | Q02763 | |
| KAKSEIEEQYVLEKG | 711 | Q6AHZ1 | |
| KGAEKAEVVETTQVY | 3681 | Q15149 | |
| YKEDTKELVVAKAGV | 126 | P41273 | |
| EVVKYIDTKNEIEEK | 291 | Q8NEG5 | |
| AYEEEKQRVGEISKK | 396 | Q01118 | |
| VYVEEKAIGTLIVTK | 516 | P22735 | |
| YTEVVVDGEITKTAK | 41 | Q9H0M0 | |
| KGTEDEVEKYSESVK | 51 | P07951 | |
| VYTGEEILQKKEITI | 641 | P17948 | |
| GKTEDVLVKFKEYQD | 81 | Q96SR6 | |
| AELIAEKIGEDYVKD | 501 | P06737 | |
| EKIGEDYVKDLSQLT | 506 | P06737 | |
| YEIKDGSLLEVEKVS | 91 | A7MCY6 | |
| AYVEKGILDKEEAEA | 446 | Q8WXD2 | |
| YKEKGVETLQEIDRK | 116 | Q9ULE0 | |
| YCGTIVTEEGKEKKV | 96 | P62495 | |
| SKIVVEEGGYEAICK | 116 | P41229 | |
| ETGDLYAVKVLKKDV | 376 | P24723 | |
| ISVKVIDDEEYEKNK | 606 | P32418 | |
| LVVKSVTDKDAGDYL | 2206 | Q9NR99 | |
| LGTAYSKVVKLEVEV | 196 | O15146 | |
| KCYVLVEVKESGGEE | 61 | Q13459 | |
| AEKEDEGVYTVTVKN | 741 | Q14896 | |
| VTAKQSGEILDDIKY | 4166 | P20929 |